{"text": "Rifampicin is a potent inducer of the CYP450 and decrease the plasmatic concentration of NNRTI and Protease Inhibitors .In our study we are going to compare the 600 an 800 mg doses of efavirenz concomitant of rifampicin use to treat tuberculosis .", "label": "", "metadata": {}, "score": "21.874866"}
{"text": "These anti - TB agents , the rifamycins -- a family that includes rifampin and rifabutin -- accelerate the metabolism of protease inhibitors , and when these drugs are taken at the same time the rifamycins reduce blood concentrations of the protease inhibitors to ineffective levels .", "label": "", "metadata": {}, "score": "23.455856"}
{"text": "An Evaluation of the Pharmacological Interaction of Lopinavir 800 mg - Ritonavir 200 mg Combination and Rifampin in Subjects Presenting Tuberculosis , With Contraindication for Antiretroviral Regimens Including Efavirenz .", "label": "", "metadata": {}, "score": "25.065222"}
{"text": "What your care provider needs to consider : .Although a multicenter international trial has shown that six months of anti - TB therapy with a regimen containing rifabutin was as effective as therapy with a similar regimen containing rifampin , rifabutin is not currently approved by the F.D.A. for the treatment or prevention of TB .", "label": "", "metadata": {}, "score": "27.143946"}
{"text": "Nearly 19 % of patients had major drug interactions recorded in their notes .The most common severe interactions were between the NNRTI drugs efavirenz and nevirapine and the TB drug rifampicin , which lowers the level of ARVs in the body .", "label": "", "metadata": {}, "score": "28.006618"}
{"text": "This results in frequent changes in drug regimens in hospitalized patients coinfected with HIV and TB 9 .All tuberculostatics are potentially hepatotoxic , particularly rifampicin and isoniazid .", "label": "", "metadata": {}, "score": "29.443893"}
{"text": "Abstract No . 688 .From web site ( ) .Centers for Disease Control and Prevention .Notice to readers : updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV - infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors .", "label": "", "metadata": {}, "score": "29.740498"}
{"text": "Detailed Description .The study consist in a open label randomized clinical trial comparing efavirenz 600 mg QID versus efavirenz 800 mg QID in patients with tuberculosis ( treated with regimens including rifampicin ) and AIDS diagnosis .", "label": "", "metadata": {}, "score": "29.79415"}
{"text": "The other variables tested lost significance when analyzed together , thus constituting confounding factors for the risk of hepatotoxicity .Discussion .Isoniazid , rifampicin and pyrazinamide are the principal agents successfully used for treating tuberculosis , due to their therapeutic effectiveness and the good acceptance of these drugs among patients .", "label": "", "metadata": {}, "score": "29.990612"}
{"text": "Pharmacokinetics of adjusted - dose lopinavir - ritonavir combined with rifampin in healthy volunteers .Antimicrob .Agents Chemother 48:1553 - 1560 2004 .MMWR Updated guidelines for the use of rifamycins for the treatment of tuberculosis among HIV - infected patients taking protease inhibitors or Nonnucleoside reverse transcriptase inhibitors , version 1.20.2004 .", "label": "", "metadata": {}, "score": "30.451488"}
{"text": "Treating active TB with regimens that do not include rifampin also carries risks , however .Because persistent TB infection is associated with more rapid progression of HIV disease , the C.D.C. does not recommend treating rifampin - susceptible TB with regimens that do not contain that drug .", "label": "", "metadata": {}, "score": "30.785925"}
{"text": "Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800 mg .Official Title ICMJE .Anti - retroviral Efficacy , Tolerance and Other Pharmacologic Interactions of the Non Nucleoside Analog Efavirenz in Association With Rifampicin to Treat Tuberculosis and AIDS .", "label": "", "metadata": {}, "score": "31.709082"}
{"text": "Pharmacokinetic interactions with rifampicin : clinical relevance .Clin Pharmacokinet 2003 ; 42:819 - 50 .[Links ] .Korenromp EL , Scano F , Williams BG , Dye C , Nunn P. Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin - based treatment : an analytical review .", "label": "", "metadata": {}, "score": "31.979197"}
{"text": "Tuberculosis .HIV Infections .Intervention ICMJE .Drug : efavirenz .600 mg X 800 mg QID during TB therapy with rifampicin associated with other antituberculosis drugs in patients concomitant treated for tuberculosis and AIDS .", "label": "", "metadata": {}, "score": "33.25648"}
{"text": "Long - term carcinogenicity studies were conducted with rifabutin in mice and in rats .Rifabutin was not carcinogenic in mice at doses up to 180 mg / kg / day , or approximately 36 times the recommended human daily dose .", "label": "", "metadata": {}, "score": "34.921417"}
{"text": "Essential anti - tuberculosis ( ATT ) drugs Isoniazid ( H ) , Rifampicin ( R ) , Ethambutol ( E ) , Pyrazinamide ( Z ) and Streptomycin ( S ) are the essential first line anti - tuberculosis drugs .", "label": "", "metadata": {}, "score": "35.045517"}
{"text": "Protease Inhibitor Drug Interaction .Protease inhibitors act as substrates or inhibitors of CYP3A4 mediated metabolism .Therefore , due to significant drug - drug interactions between protease inhibitors and rifabutin , their concomitant use should be based on the overall assessment of the patient and a patient - specific drug profile .", "label": "", "metadata": {}, "score": "35.159496"}
{"text": "Isoniazid and rifampicin resistance can be reliably measured ; resistance to pyrazinamide , ethambutol , and streptomycin is more difficult due to limitations of technique .", "label": "", "metadata": {}, "score": "35.408024"}
{"text": "Ungo et al .16 reported that chronic infection with the hepatitis C virus increased the risk of hepatotoxicity among patients treated for tuberculosis with isoniazid , pyrazinamide and rifampicin .", "label": "", "metadata": {}, "score": "35.779373"}
{"text": "In rabbits , at 80 mg / kg / day ( about 5 times the recommended human daily dose based on body surface area comparisons ) , rifabutin caused maternotoxicity and increase in fetal skeletal anomalies .", "label": "", "metadata": {}, "score": "35.805866"}
{"text": "Therapeutic regimens for tuberculosis without rifampin are less efficient , extend the negative baciloscopy , are associated with the biggest mortality besides being longer ( 1 year ) and use an injectable drug during the first 3 months ( streptomycin ) .", "label": "", "metadata": {}, "score": "35.89383"}
{"text": "This is a pharmacokinetic , descriptive , open - label , prospective , multicentric , national study in Aids and tuberculosis co - infected patients , to be laboratory and clinically monitored during the treatment with lopinavir - ritonavir and rifampin medications .", "label": "", "metadata": {}, "score": "35.920635"}
{"text": "ADVERSE REACTIONS .Post - Marketing Experience .WARNINGS AND PRECAUTIONS .Skeletal Muscle .Physicians considering combined therapy with Lipitor nd fibric acid erivatives , erythromycin , clarithromycin , a combination of saquinavir plus ritonavir , lopinavir plus ritonavir , darunavir plus ritonavir , fosamprenavir , or fosamprenavir plus ritonavir , azole antifungals , ... .", "label": "", "metadata": {}, "score": "37.245464"}
{"text": "Stocrin .Sustiva .Study Arm ( s ) .Experimental : EFAVIRENZ 800 mg .Efavirenz 800 mg ( tablet ) PO QD during 5 months associated with two nucleoside analogs during tuberculosis therapy with rifampicin .", "label": "", "metadata": {}, "score": "37.355213"}
{"text": "Antimicrob Agents Chemother 2001 Feb;45(2):502 - 8 .Rifadin ( rifampin ) US prescribing information .Sanofi - Aventis U.S. LLC February , 2013 .Justesen US , Andersen AB , Klitgaard NA , Brosen K , Gerstoft J , Pedersen C. Pharmacokinetic interaction between rifampin and the combination of indinavir and low - dose ritonavir in HIV - infected patients .", "label": "", "metadata": {}, "score": "39.611763"}
{"text": "Antiretroviral therapy is not a cure for HIV infection ; opportunistic infections and other complications associated with HIV disease may still occur .Advise patients that sustained decreases in plasma HIV RNA have been associated with reduced risk of progression to acquired immunodeficiency syndrome ( AIDS ) and death .", "label": "", "metadata": {}, "score": "39.677666"}
{"text": "Please refer to this study by its ClinicalTrials.gov identifier : NCT00771498 .Tuberculosis Actinomycetales Infections Bacterial Infections Gram - Positive Bacterial Infections Mycobacterium Infections Lopinavir Rifampin Anti - Bacterial Agents Anti - HIV Agents Anti - Infective Agents Anti - Retroviral Agents .", "label": "", "metadata": {}, "score": "39.77602"}
{"text": "Patient has a previous history of hypersensitivity or known resistance or acquired to rifampin or to lopinavir - ritonavir .Evidence of toxic substances abuse , such as alcohol and/or illicit drugs ( Attachment B ) .", "label": "", "metadata": {}, "score": "40.59924"}
{"text": "In fact , not adhering to this principle is responsible in part for the very existence of strains of MDR - TB , since therapy with only one active drug will inevitably lead to the development of resistant organisms .", "label": "", "metadata": {}, "score": "40.80083"}
{"text": "Antimycobacterials ( rifabutin , rifampin , rifapentine ) .Rifabutin : Increased rifabutin concentrations ; possible decreased ritonavir concentrations 1 30 65 141 209 .Rifampin : Decreased ritonavir concentrations may lead to loss of virologic response 1 58 209 .", "label": "", "metadata": {}, "score": "41.058884"}
{"text": "Active Comparator : EFAVIRENZ 600 mg .Efavirenz 600 mg ( tablet ) PO QD during 5 months associated with two nucleoside analogs during tuberculosis therapy with rifampicin .", "label": "", "metadata": {}, "score": "41.173615"}
{"text": "What are the symptoms of multidrug - resistant TB ?Tuberculosis that is resistant to two or more of the first - line drugs used to treat TB -- that is , TB resistant to isoniazid and rifampin , with or without resistance to either pyrazinamide , ethambutol , or streptomycin -- is known as multidrug - resistant tuberculosis , or MDR - TB .", "label": "", "metadata": {}, "score": "41.448013"}
{"text": "This two - drug anti - TB regimen permits the reintroduction of protease inhibitor therapy .Some experts recommend the addition of streptomycin or pyrazinamide to the patient 's anti - TB regimen , if test results show that the infecting organism is susceptible to the third drug .", "label": "", "metadata": {}, "score": "41.483986"}
{"text": "There were 23 major interactions involving protease inhibitors ( almost all either boosted lopinavir or nelfinavir ) and a variety of drugs including the antacids lansoprazole and omeprazole , rifampicin again , and a couple of interactions involving fluoxetine ( Prozac ) and the antimalarial combination artemether plus lumefantrine .", "label": "", "metadata": {}, "score": "41.59472"}
{"text": "Pregnancy .Pregnancy Category B .Rifabutin should be used in pregnant women only if the potential benefit justifies the potential risk to the fetus .", "label": "", "metadata": {}, "score": "41.910835"}
{"text": "The insidious interaction of these two drug classes creates a dilemma when patients who are taking protease inhibitors develop TB .Physicians and other healthcare providers recognize that untreated tuberculosis can prove fatal in patients with advanced HIV infection , so prompt and aggressive therapy is required .", "label": "", "metadata": {}, "score": "42.234974"}
{"text": "The most frequently prescribed therapeutic regimen for tuberculosis was isoniazid + rifampicin + pyrazinamide ( IRZ ) for a period of six months ( regimen I ) for both the cases and controls .", "label": "", "metadata": {}, "score": "42.25431"}
{"text": "This diagnostic dilemma led the C.D.C. to propose that doctors who treat people with HIV consider using isoniazid , one of the most powerful of the first - line drugs used to treat TB , as prophylaxis against infection in people likely to have been exposed to tuberculosis .", "label": "", "metadata": {}, "score": "42.366905"}
{"text": "[ PubMed 8627733 ] .Hsu A , Granneman GR , Cao G et al .Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors , ritonavir and saquinavir .", "label": "", "metadata": {}, "score": "42.685158"}
{"text": "Inhibits replication of HIV by interfering with HIV protease .HIV-1 with reduced susceptibility to ritonavir have been selected in vitro and have emerged during therapy with the drug .", "label": "", "metadata": {}, "score": "43.2005"}
{"text": "[ IDIS 405471 ] [ PubMed 9585800 ] .Lorenzi P , Yearly S , Abderrakim K et al .Toxicity , efficacy , plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir .", "label": "", "metadata": {}, "score": "43.254505"}
{"text": "However , the use of combined antiretroviral therapy in individuals undergoing treatment for tuberculosis may increase the risk of toxicity , drug interactions and other adverse effects 6 .", "label": "", "metadata": {}, "score": "43.596447"}
{"text": "[Links ] .Mcneill L , Alen M , Estrada C , Cook P. Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis : improved completion rates but more hepatotoxicity .", "label": "", "metadata": {}, "score": "43.658974"}
{"text": "[ IDIS 373812 ] [ PubMed 8813040 ] .Sun E , Heath - Chiozzi M , Cameron DW et al .Concurrent ritonavir and rifabutin increases risk of rifabutin - associated adverse effects .", "label": "", "metadata": {}, "score": "44.032803"}
{"text": "The single most powerful predictor of the presence of MDR - TB is a history of previous treatment for tuberculosis . \"Because the symptoms of tuberculosis in people with HIV are so nonspecific , the key to accurate diagnosis is a high degree of suspicion -- and the inclusion of tuberculosis in the differential diagnosis .", "label": "", "metadata": {}, "score": "44.21402"}
{"text": "[ IDIS 418513 ] [ PubMed 9480994 ] .Lorenzi P , Yerly S , Abderrakim K et al .Toxicity , efficacy , plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir .", "label": "", "metadata": {}, "score": "44.4353"}
{"text": "Rifabutin was not mutagenic in the bacterial mutation assay ( Ames Test ) using both rifabutinsusceptible and resistant strains .Rifabutin was not mutagenic in Schizosaccharomyces pombe P1 and was not genotoxic in V-79 Chinese hamster cells , human lymphocytes in vitro , or mouse bone marrow cells in vivo .", "label": "", "metadata": {}, "score": "44.693806"}
{"text": "According to Merck , the makers of indinavir , rifabutin at a daily dose of 150 mg will provide effective MAC prophylaxis in patients taking this protease inhibitor .", "label": "", "metadata": {}, "score": "44.928093"}
{"text": "The cases were also more likely to start their antiretroviral therapy before the tuberculosis treatment , with a slight predominance of non - nucleoside reverse transcriptase inhibitor regimens .", "label": "", "metadata": {}, "score": "44.93313"}
{"text": "A genotyping during screening will be conducted in order to optimize the combination therapy .Antituberculosis treatment will consist on rifampin ( 600 mg / daily ) isoniazide and ( 400 mg / daily ) , both in fasting condition and for 6 months ; and pirazinamide ( 2.000 mg ) for the first two months , according to the Ministry of Health recommendations .", "label": "", "metadata": {}, "score": "44.9365"}
{"text": "Drug - related hepatotoxicity may be fatal if detected at a late stage .Rapid recognition of the inherent conditions and risk factors is of great importance to ensure the best possible care for hospitalized patients who are undergoing tuberculosis treatment and are coinfected with HIV .", "label": "", "metadata": {}, "score": "44.962914"}
{"text": "In patients taking the HIV protease inhibitor lopinavir plus ritonavir , caution should be used when prescribing Lipitor and the lowest dose necessary should be used .", "label": "", "metadata": {}, "score": "45.130817"}
{"text": "[ IDIS 435511 ] [ PubMed 10546917 ] .Scott G , Shapiro D , Scott W et al .Safety and tolerance of ritonavir in combination with lamivudine and zidovudine in HIV-1 infected pregnant women and their infants .", "label": "", "metadata": {}, "score": "45.424812"}
{"text": "[IDIS 433125 ] [ PubMed 10458617 ] .Michelet C , Bellissant E , Ruffault A et al .Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine .", "label": "", "metadata": {}, "score": "46.563927"}
{"text": "Safety and effectiveness of rifabutin for prophylaxis of MAC in children have not been established .Limited safety data are available from treatment use in 22 HIV - positive children with MAC who received MYCOBUTIN in combination with at least two other antimycobacterials for periods from 1 to 183 weeks .", "label": "", "metadata": {}, "score": "46.8095"}
{"text": "Furthermore , efforts have not been made to establish evidence that can support the use of a potent antiretroviral agent within the context of rescue regimens , among HAART - experienced patients .", "label": "", "metadata": {}, "score": "46.823784"}
{"text": "Pharmacokinetics of adjusted - dose lopinavir - ritonavir combined with rifampin in healthy volunteers .Antimicrob Agents Chemother 2004 May;48(5):1553 - 60 .J Acquir Immune Defic Syndr 2005 Nov 1;40(3):317 - 23 .", "label": "", "metadata": {}, "score": "47.03337"}
{"text": "[Links ] .Ohno M , Yamaguchi I , Yamamoto I , Fukuda T , Yokota S , Maekura R , et al .Slow N - acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin - induced hepatotoxicity .", "label": "", "metadata": {}, "score": "47.09871"}
{"text": "Given the extremely high mortality from MDR - TB in HIV - infected patients , it is imperative that treatment occur under the supervision of physicians who are experts in the management of tuberculosis .", "label": "", "metadata": {}, "score": "47.281918"}
{"text": "[ PubMed 9696850 ] .Cato A , Quin J , Hsu A et al .Multidose pharmacokinetics of ritonavir and zidovudine in human immunodeficiency virus - infected patients .", "label": "", "metadata": {}, "score": "47.30436"}
{"text": "Adverse effects ( e.g. , GI , paresthesias ) may lessen with continued therapy .Pediatric Patients .Treatment of HIV Infection .Full - dose Ritonavir .", "label": "", "metadata": {}, "score": "47.350945"}
{"text": "For patients who will be re - treated for tuberculosis , etambutol will be added in a dose of 1.200 mg / daily during the 6-month treatment .", "label": "", "metadata": {}, "score": "47.485504"}
{"text": "[ PubMed 15040537 ] .Food and Drug Administration .FDA drug safety communication : Important drug interactions between Victrelis ( boceprevir ) and ritonavir - boosted human immunodeficiency virus ( HIV ) protease inhibitor drugs .", "label": "", "metadata": {}, "score": "47.706528"}
{"text": "[ IDIS 415414 ] [ PubMed 9652687 ] .Mueller BU , Nelson RP Jr , Sleasman J et al .A phase I / II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infection .", "label": "", "metadata": {}, "score": "47.74315"}
{"text": "Objectives : .Evaluate the pharmacokinetics of lopinavir-800 mg / ritonavir-200 mg combination ( every 12 h ) in association with rifampin - containing anti - tuberculosis regimens , in patients presenting tuberculosis and HIV - infected with indication to antiretroviral treatment according to Brazilian Ministry of Health 's guidelines , with contraindication to the use of NNTRI .", "label": "", "metadata": {}, "score": "47.758656"}
{"text": "However , the minimum plasma concentration with the combination of lopinavir 800mg - ritonavir 200 mg was lower in some timepoints than that recommended to achieve a good virologic effect .", "label": "", "metadata": {}, "score": "47.8454"}
{"text": "1998 ; 12:F97 - 102 .[ PubMed 9677159 ] .Reddy SS .Dear healthcare professional letter .Results of pharmacokinetic study in healthy volunteers given Victrelis ( boceprevir ) and ritonavir - boosted HIV protease inhibitors may indicate clinically significant drug interactions for patients coinfected with chronic hepatitis C and HIV .", "label": "", "metadata": {}, "score": "48.024"}
{"text": "At one time HIV experts thought that they might be able to increase the sensitivity of the tuberculin test by conducting the test in two stages , with the first test serving as a \" booster \" to the second , but this did not prove possible .", "label": "", "metadata": {}, "score": "48.34233"}
{"text": "Yuen G , Anderson R , Daniels R et al .Investigation of nelfinavir mesylate ( NFV ) pharmacokinetic ( PK ) interactions with indinavir ( IDV ) and ritonavir ( RTV ) .", "label": "", "metadata": {}, "score": "48.57141"}
{"text": "[ IDIS 367929 ] [ PubMed 8648209 ] .Collier AC , Coombs RW , Schoenfeld DA et al et al .Treatment of human immunodeficiency virus infection with saquinavir , zidovudine , and zalcitabine .", "label": "", "metadata": {}, "score": "48.58468"}
{"text": "December , 2004 .Stribild ( elvitegravir , cobicistat , emtricitabine , tenofovir ) prescribing information .Gilead Sciences , Inc.July , 2015 .Centers for Disease Control and Prevention Division of Tuberculosis Elimination .", "label": "", "metadata": {}, "score": "48.942852"}
{"text": "In case of occurrence of gastrointestinal intolerance to rifampin , this one may be used after breakfast , but these data should be recorded in the patient chart in order to correlate it with pharmacokinetics data .", "label": "", "metadata": {}, "score": "49.011997"}
{"text": "Moreover , we now know that certain groups are at much higher risk of developing tuberculosis that is resistant to one or more of the drugs that are used to treat this infection .", "label": "", "metadata": {}, "score": "49.028236"}
{"text": "The most common antiretroviral drugs used were , in this order , 3TC , d4 T , and nevirapine ( given largely as the Triomune combined pill ) ; then AZT and efavirenz ; then smaller numbers on other NRTIs and on protease inhibitors .", "label": "", "metadata": {}, "score": "49.355297"}
{"text": "In the investigator 's opinion , patient predicts a low compliance to the proposed study according to the clinical history for a given subject .Patient with history of prior use of Kaletra \u00ae ( lopinavir , ritonavir ) with comproved virologic or genotypic failure or serious intolerance needing change of antiretroviral treatment .", "label": "", "metadata": {}, "score": "49.6307"}
{"text": "Combination of Protease Inhibitors : .Atorvastatin AUC was significantly increased with concomitant administration of Lipitor with several combinations of HIV protease inhibitors , as well as with the hepatitis C protease inhibitor telaprevir , compared to that of Lipitor alone .", "label": "", "metadata": {}, "score": "49.708443"}
{"text": "Patients who present contraindication for NNRTI use .Contraindication may be obtained through a history of virologic resistance ( prior use of efavirenz with comproved virologic failure in a subject with good adherence ) , genotyping test indicative of mutations that provide resistance to these drugs , intolerance , or hypersensitivity .", "label": "", "metadata": {}, "score": "49.789078"}
{"text": "The clinical presentation of MDR - TB does not differ substantially from that of tuberculosis caused by drug - susceptible bacilli .In HIV - infected patients , as in other populations , tuberculosis is primarily a pulmonary infection , although infection outside the lungs occurs in up to 40 % of patients infected with both HIV and TB .", "label": "", "metadata": {}, "score": "50.1124"}
{"text": "If boceprevir was initiated for treatment of chronic HCV in a patient coinfected with HIV receiving a suppressive antiretroviral regimen containing a ritonavir - boosted HIV PI , inform patient of possible drug interaction and closely monitor for HCV treatment response and potential HCV and HIV virologic rebound 112 117 118 200 .", "label": "", "metadata": {}, "score": "50.31171"}
{"text": "Nursing Mothers .It is not known whether rifabutin is excreted in human milk .Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants , a decision should be made whether to discontinue nursing or discontinue the drug , taking into account the importance of the drug to the mother .", "label": "", "metadata": {}, "score": "50.34388"}
{"text": "[ IDIS 357352 ] [ PubMed 7477167 ] .Kempf DJ , Marsh KC , Denissen JF et al .ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans .", "label": "", "metadata": {}, "score": "50.439255"}
{"text": "During this period patients can continue to take , or can switch to , combination antiretroviral therapies -- such as AZT or d4 T plus 3TC and nevirapine -- that do not include protease inhibitors .", "label": "", "metadata": {}, "score": "50.607803"}
{"text": "The C.D.C. offers three options for patients who develop active TB while they are taking a protease inhibitor as part of their antiretroviral therapy .OPTION # 1 : Discontinue protease inhibitor therapy until you have completed a six - month course of anti - TB therapy with a regimen that contains rifampin .", "label": "", "metadata": {}, "score": "50.7025"}
{"text": "For patients with previous history of TB therapy etambutol 1.200 mg QID will be added to the regimen .Both groups will receive nucleoside reverse transcriptase inhibitors ( NRTI)and a non nucleoside transcriptase inhibitor ( NNRTI ) to treat HIV .", "label": "", "metadata": {}, "score": "50.749573"}
{"text": "There are rare exceptions to this rule , but from a practical point of view all HIV - infected persons should be treated with this four - drug regimen until their drug susceptibility data become available .", "label": "", "metadata": {}, "score": "50.870827"}
{"text": "Treating multidrug - resistant TB .Only laboratory testing can determine whether a strain of tuberculosis is drug - resistant .These same tests tell your care provider which drugs your particular strain of TB will respond to .", "label": "", "metadata": {}, "score": "50.88326"}
{"text": "Clostridium Difficile Associated Diarrhea .Clostridium difficile associated diarrhea ( CDAD ) has been reported with use of nearly all antibacterial agents , including MYCOBUTIN ( rifabutin ) Capsules , USP , and may range in severity from mild diarrhea to fatal colitis .", "label": "", "metadata": {}, "score": "50.99337"}
{"text": "Links ] .Dean GL , Edwards SG , Ives NJ , Matthews G , Fox EF , Navaratne L , et al .Treatment of tuberculosis in HIV - infected persons in the era of highly active antiretroviral therapy .", "label": "", "metadata": {}, "score": "51.472473"}
{"text": "Mo .B.1201 .Mueller BU , Nelson RP , Sleasman J et al .A phase I / II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infection .", "label": "", "metadata": {}, "score": "51.83615"}
{"text": "Letter [ PubMed 10615321 ] .Chadwick EG , Rodman JH , Britto P et al .Ritonavir - based hightly active antiretroviral therapy in human immunodeficiency virus type 1-infected infants younger than 24 months of age .", "label": "", "metadata": {}, "score": "51.88428"}
{"text": "[ IDIS 428312 ] [ PubMed 10391672 ] .Sulkowski MS , Thomas DL , Charisson Re et al .Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection .", "label": "", "metadata": {}, "score": "51.994072"}
{"text": "Until recently , TB was not perceived as a particular threat to HIV - positive individuals in this country -- but that was before the emergence of new strains of tuberculosis , strains that are resistant to one or more of the drugs used to treat this infection .", "label": "", "metadata": {}, "score": "52.272606"}
{"text": "Links ] .Nolan CM , Goldberg SV , Buskin SE .Hepatotoxicity associated with isoniazid preventive therapy .A 7-year survey from a Public Health Tuberculosis Clinic .", "label": "", "metadata": {}, "score": "52.337563"}
{"text": "[ IDIS 388621 ] [ PubMed 9145904 ] .Deeks SG , Grant RM , Beatty GW et al .Activity of a ritonavir plus saquinavir - containing regimen in patients with virologic evidence of indinavir or ritonavir failure .", "label": "", "metadata": {}, "score": "52.552235"}
{"text": "[ IDIS 370344 ] [ PubMed 8709686 ] .Hsu A , Granneman GR , Witt G et al .Assessment of multiple doses of ritonavir on the pharmacokinetics of theophylline .", "label": "", "metadata": {}, "score": "52.736286"}
{"text": "[ IDIS 462835 ] [ PubMed 11242194 ] .Kempf DJ , Marsh KC , Kumar G et al .Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir .", "label": "", "metadata": {}, "score": "52.79837"}
{"text": "Drug : Lopinavir .La Porte et al ( 2004 ) presented the results of a pharmacokinetic study using two other dosage regimens , lopinavir-400mg / ritonavir-400 mg and lopinavir-800mg / ritonavir-200 mg co - administered with rifampin in healthy volunteers .", "label": "", "metadata": {}, "score": "53.014355"}
{"text": "[ PubMed 9056009 ] .Kumar GN , Rodrigues AD , Buko AM et al .Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir ( ABT-538 ) in human liver microsomes .", "label": "", "metadata": {}, "score": "53.25416"}
{"text": "[ PubMed 8613951 ] .Jacobsen H , H\u00e4nggi M , Ott M et al .In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor : mutations , kinetics , and frequencies .", "label": "", "metadata": {}, "score": "53.45179"}
{"text": "Danner SA , Carr A , Leonard JM et al et al .A short - term study of the safety , pharmacokinetics , and efficacy of ritonavir , an inhibitor of HIV-1 protease .", "label": "", "metadata": {}, "score": "53.496113"}
{"text": "An abnormality in the antioxidant profile with increased peroxidation would suggest that hepatotoxicity induced by rifampicin and isoniazid is mediated by oxidative damage 14 .The frequency of occurrence of isoniazid - associated hepatitis depends on age .", "label": "", "metadata": {}, "score": "53.569977"}
{"text": "Links ] .Yee D , Valiquette C , Pelletier M , Parisien J , Rocher J , Menzies D. Incidence of serious side effects from first - line antituberculosis drugs among patient streated for active tuberculosis .", "label": "", "metadata": {}, "score": "53.73049"}
{"text": "Fixed dose combinations ( FDCs ) drugs consisting of two or three antituberculosis medications , provide a realistic and welcome alternative to DO that minimizes the opportunity for a patient to selectively take only a single medication .", "label": "", "metadata": {}, "score": "53.950527"}
{"text": "Cyclosporine , HIV protease inhibitors ( tipranavir plus ritonavir ) , hepatitis C protease inhibitor ( telaprevir ) : Avoid atorvastatin .HIV protease inhibitor ( lopinavir plus ritonavir ) : Use with caution and lowest dose necessary ... .", "label": "", "metadata": {}, "score": "54.07524"}
{"text": "Dear Healthcare Provider Letter .Subject : Important drug interaction warning for saquinavir .Roche Laboratories , Inc. February 9 , 2005 .Dear Canadian Healthcare Professional letter : Subject : Drug - induced hepatitis with marked transaminase elevations in healthy volunteers receiving rifampin 600 mg once daily in combination with ritonavir 100 mg / saquinavir 1000 mg twice daily .", "label": "", "metadata": {}, "score": "54.109238"}
{"text": "OPTION # 3 : Continue protease inhibitor therapy with indinavir ( 800 mg every 8 hours ) and administer a four - drug , nine - month anti - TB regimen , substituting rifabutin ( 150 mg daily ) for rifampin .", "label": "", "metadata": {}, "score": "54.1181"}
{"text": "[Links ] .Singla R , Sharma SK , Mohan A , Makharia G , Sreenivas V , Jha B , et al .Evaluation of risk factors for antituberculosis treatment - induced hepatotoxicity .", "label": "", "metadata": {}, "score": "54.14821"}
{"text": "However , the dose of Kaletra \u00ae ( lopinavir / ritonavir ) will be reduced to lopinavir 400 mg / ritonavir 100 mg ( 2 tablets ) every 12 hours .", "label": "", "metadata": {}, "score": "54.256973"}
{"text": "Once bacteriologic response has been documented and the results of drug - susceptibility testing are available -- a process that usually takes three months -- treatment may be modified .", "label": "", "metadata": {}, "score": "54.416725"}
{"text": "From FDA website .Accessed 2012 Jul 9 .Lumpkin MM .Dear healthcare provider letter : Reports of diabetes and hyperglycemia in patients receiving protease inhibitors for the treatment of human immunodeficiency virus ( HIV ) .", "label": "", "metadata": {}, "score": "54.423195"}
{"text": "[ PubMed 7815532 ] .Tisdale M , Myers RE , Maschera B et al .Cross - resistance analysis of human immunodeficiency virus type 1 variants individually selected for resistance to five different protease inhibitors .", "label": "", "metadata": {}, "score": "54.478287"}
{"text": "Diabetes mellitus : The drug regimen is same as in nondiabetic .Strict control of blood glucose is mandatory .Also , doses of oral hypoglycemic agents may have to be increased due to interaction with Rifampicin .", "label": "", "metadata": {}, "score": "54.512325"}
{"text": "Cato A , Qian J , Hsu A et al .Pharmacokinetic interaction between ritonavir and didanosine when administered concurrently to HIV - infected patients .", "label": "", "metadata": {}, "score": "54.661617"}
{"text": "Selected 3A4 Substrates / Rifampin .This information is generalized and not intended as specific medical advice .Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment .", "label": "", "metadata": {}, "score": "54.850918"}
{"text": "Recently , the FDA ( Food and Drug Administration , EUA ) approved a new Kaletra ( lopinavir / ritonavir ) tablet formulation .The new formulation is based on a Meltrex \u2122 ( melt extrusion ) technology , which requires no refrigeration ( AWNI et al , 2005 ) .", "label": "", "metadata": {}, "score": "54.958683"}
{"text": "Macrolides ( clarithromycin ) .Clarithromycin : Increased AUC of ritonavir and clarithromycin ; decreased AUC of 14-hydroxyclarithromycin 1 58 130 209 .Maraviroc .", "label": "", "metadata": {}, "score": "54.962708"}
{"text": "2005 ; 6(Suppl 2):1 - 61 .Caballero - Granado FJ , Viciana P , Cordero E et al .Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient .", "label": "", "metadata": {}, "score": "55.06232"}
{"text": "Pharmacokinetic interaction ; potential for serious or life - threatening reactions ( e.g. , cardiac arrhythmias ) 1 78 209 .Patients with renal or hepatic impairment : Avoid concomitant use of colchicine and ritonavir 1 200 209 .", "label": "", "metadata": {}, "score": "55.132996"}
{"text": "The pretreatment transaminases values of the cases and controls were evaluated and those already presenting levels higher than the upper normal limit prior to the start of treatment for tuberculosis were excluded .", "label": "", "metadata": {}, "score": "55.15793"}
{"text": "General .Because treatment with MYCOBUTIN Capsules may be associated with neutropenia , and more rarely thrombocytopenia , physicians should consider obtaining hematologic studies periodically in patients receiving prophylaxis with MYCOBUTIN .", "label": "", "metadata": {}, "score": "55.22426"}
{"text": "Abstract No .428 .Cameron DW , Heath - Chiozzi M , Danner S et al for the Advanced HIV Disease Ritonavir Study Group .", "label": "", "metadata": {}, "score": "55.266785"}
{"text": "OPTION # 3 can not be recommended for patients taking either saquinavir or ritonavir , because of the strong drug - drug interactions that occur when these protease inhibitors are taken in combination with rifabutin .", "label": "", "metadata": {}, "score": "55.336006"}
{"text": "33 , Yimer et al .37 and Koju et al .44 .Concerning the clinical forms of tuberculosis , almost 50 % of the cases presented the pulmonary form , compared with 40 % of the controls , although this difference was not significant .", "label": "", "metadata": {}, "score": "55.43954"}
{"text": "If these symptoms occur , administer supportive measures and discontinue MYCOBUTIN .Uveitis .Due to the possible occurrence of uveitis , patients should also be carefully monitored when MYCOBUTIN is given in combination with clarithromycin ( or other macrolides ) and/or fluconazole and related compounds ( see PRECAUTIONS : DRUG INTERACTIONS , Table 2 ) .", "label": "", "metadata": {}, "score": "55.478676"}
{"text": "Do not refrigerate ; avoid exposure to excessive heat .Actions and Spectrum .Pharmacologically related to other PIs ( e.g. , amprenavir , atazanavir , fosamprenavir , indinavir , lopinavir , nelfinavir , saquinavir ) ; differs structurally from these drugs and also differs pharmacologically and structurally from other currently available antiretrovirals .", "label": "", "metadata": {}, "score": "55.726135"}
{"text": "[ PubMed 7708670 ] .Markowitz M , Mo H , Kempf DJ et al .Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538 , a novel protease inhibitor .", "label": "", "metadata": {}, "score": "55.78073"}
{"text": "C. difficile produces toxins A and B which contribute to the development of CDAD .Hypertoxin producing strains of C. difficile cause increased morbidity and mortality , as these infections can be refractory to antimicrobial therapy and may require colectomy .", "label": "", "metadata": {}, "score": "55.829018"}
{"text": "1997 ; 11:F95 - 9 .[ PubMed 9342060 ] .Kravcik S , Gallicano K , Roth V et al .Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir .", "label": "", "metadata": {}, "score": "55.8992"}
{"text": "The retrospective survey of patient case - notes in the AMPATH ( Academic Model for the Prevention and Treatment of HIV / AIDS ) found that altogether 30 % of patients had suffered major or minor consequences from drug interactions .", "label": "", "metadata": {}, "score": "55.921307"}
{"text": "Several principles do apply to treating MDR - TB in all HIV - infected patients , however .The single most important principle in the treatment of MDR - TB is to administer at least two drugs to which there is documented susceptibility .", "label": "", "metadata": {}, "score": "56.03901"}
{"text": "The relationship between genetic polymorphism and the toxicity of these drugs has also been investigated .This characteristic includes the cytochrome P 450 and glutathione S - transferase genes , together with genes of the major histocompatibility complex II associated with HLA - DQ alleles 13 .", "label": "", "metadata": {}, "score": "56.078285"}
{"text": "There is no evidence that MYCOBUTIN is an effective prophylaxis against M. tuberculosis .Patients requiring prophylaxis against both M. tuberculosis and Mycobacterium avium complex may be given isoniazid and MYCOBUTIN concurrently .", "label": "", "metadata": {}, "score": "56.087475"}
{"text": "Misdiagnosis of MDR - TB due to laboratory related errors has been reported recently .MANAGEMENT OF TB : .Chemotherapy of TB consists of prevention of infection , also called primary chemoprophylaxis , when isoniazid 5 mg / kg is given to prevent infection in newborn infants of infectious mothers till mother is sputum smear positive ( 2 - 3months ) .", "label": "", "metadata": {}, "score": "56.091652"}
{"text": "Abstract No . A25 .Bertz RJ , Cao G , Cavanaugh JH et al .Effect of ritonavir on the pharmacokinetics of trimethoprim / sulfamethoxazole .", "label": "", "metadata": {}, "score": "56.22168"}
{"text": "Rockstroh JK , Bergmann F , Wiesel W et al .Efficacy and safety of twice daily first - line ritonavir / indinavir plus double nucleoside combination therapy in HIV - infected individuals .", "label": "", "metadata": {}, "score": "56.226913"}
{"text": "Links ] .Sharma SK , Balamurugan A , Saha PK , Pandey RM , Mehra K. Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment .", "label": "", "metadata": {}, "score": "56.241997"}
{"text": "200 201 Regimens containing low - dose ritonavir with certain other PIs ( atazanavir , darunavir , fosamprenavir , lopinavir ) are preferred or alternative PIs for initial therapy in adults , adolescents , and children .", "label": "", "metadata": {}, "score": "56.440506"}
{"text": "[Links ] .Yew WW , Leung CC .Antituberculosis drugs and hepatotoxicity .Respirology 2006 ; 11:699 - 707 .[Links ] .", "label": "", "metadata": {}, "score": "56.528816"}
{"text": "Increased lopinavir concentrations and AUC ; 200 207 used to therapeutic advantage ( commercially available as Kaletra ; lopinavir in fixed combination with ritonavir [ lopinavir / ritonavir ] ) 200 207 .", "label": "", "metadata": {}, "score": "56.641434"}
{"text": "In addition , all HIV - infected patients with MDR - TB should be given directly observed therapy , or DOT -- that is , each dose should be taken under the direct supervision of a care provider or health department official .", "label": "", "metadata": {}, "score": "56.701664"}
{"text": "In this case , liver toxicity might be explained by higher ritonavir doses , and strategies that can reduce the ritonavir dosage to permit a lower incidence of liver toxicity and other gastrointestinal events would be of extreme practical utility .", "label": "", "metadata": {}, "score": "56.757153"}
{"text": "From FDA website .Accessed 2012 Apr 23 .Food and Drug Administration .FDA drug safety communication : Updated information on drug interactions between Victrelis ( boceprevir ) and certain boosted HIV protease inhibitor drugs .", "label": "", "metadata": {}, "score": "56.798298"}
{"text": "Increased poverty , a progressive decline in investment in the healthcare sector and the HIV pandemic have contributed towards the reappearance and persistence of this disease to the present day 2 . World Health Organization ( WHO ) estimates indicate that around 100 million people worldwide are infected with tuberculosis and that almost 8.3 million new cases appear each year , resulting in 1.8 million deaths every year 3 .", "label": "", "metadata": {}, "score": "56.81505"}
{"text": "When these two medicines are taken together , your body may process your HIV medicine more quickly .What might happen : .Your blood levels of HIV medicine may decrease and reduce its beneficial effects .", "label": "", "metadata": {}, "score": "56.999367"}
{"text": "ART for HIV , containing protease inhibitors ( PI ) and non - nucleoside reverse transcriptase inhibitors ( NNRTI ) can not be used along with R , as R induces metabolism of PI and reduces the efficacy .", "label": "", "metadata": {}, "score": "57.064873"}
{"text": "Caution advised if used with other drugs that prolong PR interval ( e.g. , some \u03b2 - adrenergic blocking agents , some calcium - channel blockers , digoxin , atazanavir ) , especially drugs metabolized by CYP3A.", "label": "", "metadata": {}, "score": "57.375286"}
{"text": "From the FDA website ( ) ; accessed 2004 Sep 24 .Clevenbergh P , Corcostegui M , G\u00e9rard D et al .Iatrogenic Cushing 's syndrome in an HIV - infected patient treated with inhaled corticosteroids ( fluticasone propionate ) and low dose ritonavir enhanced PI containing regimens .", "label": "", "metadata": {}, "score": "57.390125"}
{"text": "The median CD4 count in the study population was 240 , and 23 % of the patients had C.D.C.-defined AIDS .Confirmed TB developed in 3 of the 260 patients assigned to isoniazid , and in 6 of the 257 assigned to placebo .", "label": "", "metadata": {}, "score": "57.420208"}
{"text": "This may explain the absence of any effect relating to hepatotoxicity in the present study or any potential confounding factors , aswas demonstrated in the multivariate analysis .", "label": "", "metadata": {}, "score": "57.639786"}
{"text": "Based on these results , it was concluded that there was a high incidence of hepatotoxicity , most frequently of the jaundice variety , and a high risk of death among the hospitalized patients coinfected with HIV and undergoing tuberculosis treatment .", "label": "", "metadata": {}, "score": "57.665985"}
{"text": "This gives rise to the supposition that the presence of this side effect may have contributed in some way to the negative outcome .Thus , it might be supposed that the options of maintaining and reintroducing the regimen could have proved harmful .", "label": "", "metadata": {}, "score": "57.668655"}
{"text": "Links ] .Saukkonen JJ , Cohn DL , Jasmer RM , Schenker S , Jereb JA , Nolan CM , et al .An official ATS statement : hepatotoxicity of antituberculosis therapy .", "label": "", "metadata": {}, "score": "57.68768"}
{"text": "However , when it does cause adverse effects , its clinical manifestation is intrahepatic cholestasis , caused by competition with glucuronyltransferase 10 .The most important adverse effects of isoniazid are hepatic toxicity and potentially fatal drug - induced hepatitis 11 , especially when associated with rifampicin .", "label": "", "metadata": {}, "score": "57.724358"}
{"text": "However , there was a higher rate of liver toxicity in the lopinavir-400mg / ritonavir-400 mg dose arm , with grade 2/3 ALT / SGTP elevations occurring in 5 subjects compared to 2 subjects in the lopinavir-800mg / ritonavir-200 mg dose arm .", "label": "", "metadata": {}, "score": "57.768127"}
{"text": "Asymptomatic HIV - infected individuals and those with AIDS are much more susceptible to infection with tuberculosis than those without HIV infection 2,3,4,6,7 .Worldwide , nine percent of all new tuberculosis cases in adults in the age range 15 - 49 years are attributable to HIV infection 3 .", "label": "", "metadata": {}, "score": "57.787003"}
{"text": "Anti - TB therapy should last at least six months , and treatment should be prolonged if your response is slow or suboptimal .Directly - observed therapy is routinely recommended for the treatment of TB , to ensure a high level of adherence with the standard four - drug regimen .", "label": "", "metadata": {}, "score": "57.947006"}
{"text": "For hepatoxicity defined as an increase in ALT ( alanine aminotransferase ) levels of up to three times the lower normal limit , the frequency of hepatotoxicity was greater in the group of patients also infected with HIV 17 .", "label": "", "metadata": {}, "score": "58.071857"}
{"text": "This scenario seems favourable for countries like Africa , where a refrigerator is a limitant condition for patients and treatment sites .A strategy of using tablets , without additional ritonavir seems promising .", "label": "", "metadata": {}, "score": "58.457085"}
{"text": "Tablets .Administer orally with a meal .209Swallow tablet whole ; do not break , chew , or crush .Dosage .Must be given in conjunction with other antiretrovirals . 1 Low - dose ritonavir is used with certain PIs ( atazanavir , darunavir , fosamprenavir , indinavir , saquinavir , tipranavir ) in ritonavir - boosted regimens .", "label": "", "metadata": {}, "score": "58.519276"}
{"text": "Describe clinical , immunological and virological endpoints throughout the study with these drugs .Endpoint Classification : Pharmacokinetics Study Intervention Model : Single Group Assignment Masking : Open Label .", "label": "", "metadata": {}, "score": "58.57087"}
{"text": "[ IDIS 408216 ] [ PubMed 9661022 ] .Burger DM , Hugen PWH , Aarnoutse RE et al .A retrospective , cohort - based survey of patients using twice - daily indinavir + ritonavir combinations ; pharmacokinetics , safety , and efficacy .", "label": "", "metadata": {}, "score": "58.60459"}
{"text": "In cases where enterostomy has been performed or parenteral nutrition is being used , intramuscular streptomycin and isoniazid and intravenous quinolones may be used and switch to oral therapy once oral feed resume .", "label": "", "metadata": {}, "score": "58.6874"}
{"text": "Ann Intern Med .[ IDIS 339373 ] [ PubMed 7978715 ] .Hardy DJ , Swanson RN , Rode RA et al .Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy clarithromycin , its major metabolite in humans .", "label": "", "metadata": {}, "score": "58.80885"}
{"text": "[ PubMed 10894282 ] .American Thoracic Society ( ATS ) and Centers for Disease Control and Prevention ( CDC ) .Targeted tuberculin testing and treatment of latent tuberculosis infections .", "label": "", "metadata": {}, "score": "58.82515"}
{"text": "Potential for decreased ritonavir concentrations in patients with moderate hepatic impairment ; monitor carefully . 1 209 Not studied in severe hepatic impairment .Voriconazole : Concomitant use with ritonavir 400 mg twice daily contraindicated 1 209 .", "label": "", "metadata": {}, "score": "58.87146"}
{"text": "Mycobutin .WARNINGS .Tuberculosis .MYCOBUTIN Capsules must not be administered for MAC prophylaxis to patients with active tuberculosis .Patients who develop complaints consistent with active tuberculosis while on prophylaxis with MYCOBUTIN should be evaluated immediately , so that those with active disease may be given an effective combination regimen of anti - tuberculosis medications .", "label": "", "metadata": {}, "score": "58.92085"}
{"text": "in the Newsline section of this issue ) .While we do not have a way of telling , with absolute certainty , if an individual who is HIV - positive has been exposed to TB , we do know that certain groups are at higher risk of TB infection than others .", "label": "", "metadata": {}, "score": "59.01966"}
{"text": "The C.D.C. , recognizing that the management of these patients is complex , has issued guidelines for the care of individuals who are infected with both HIV and TB .", "label": "", "metadata": {}, "score": "59.12486"}
{"text": "The regimen for liver diseases izoniazid + streptomicin + ethambutol was instituted solely for patients in the case group .This variable was not subjected to statistical tests because of the small number of patients in each category ( Table 3 ) .", "label": "", "metadata": {}, "score": "59.259758"}
{"text": "Ritonavir - boosted PIs ( e.g. , ritonavir - boosted atazanavir , ritonavir - boosted darunavir , lopinavir / ritonavir ) : Decreased concentrations and AUC of boceprevir and the HIV PIs ; 117 185 200 possible reduced efficacy of HCV and HIV treatment regimens 117 118 .", "label": "", "metadata": {}, "score": "59.271202"}
{"text": "Excipients in commercially available drug preparations may have clinically important effects in some individuals ; consult specific product labeling for details .Comparative Pricing .This pricing information is subject to change at the sole discretion of DS Pharmacy .", "label": "", "metadata": {}, "score": "59.34273"}
{"text": "Increased monitoring for adverse events is recommended when using these drug combinations ( see PRECAUTIONS : DRUG INTERACTIONS ) .For further recommendations , please refer to current , official product monographs of the protease inhibitor or contact the specific manufacturer .", "label": "", "metadata": {}, "score": "59.411873"}
{"text": "Food and Drug Administration .FDA drug safety communication : Interactions between certain HIV or hepatitis C drugs and cholesterol - lowering statin drugs can increse the risk of muscle injury .", "label": "", "metadata": {}, "score": "59.515255"}
{"text": "Hepatotoxicity consisted of jaundice or a high concentration of AST / ALT or total bilirubinemia .Coinfection with the B and C hepatitis virus and a T CD4 + cell count below 200cells / mm 3 were independent risk factors for hepatotoxicity in these patients .", "label": "", "metadata": {}, "score": "59.662666"}
{"text": "[ IDIS 363488 ] [ PubMed 8598838 ] .Merrill DP , Moonis M , Chou TC et al .Lamivudine or stavudine in two- and three - drug combinations against human immunodeficiency virus type 1 replication in vitro .", "label": "", "metadata": {}, "score": "59.673843"}
{"text": "[PubMed 12580992 ] .Gazzard B , for the BHIVA Guidelines Writing Committee .British HIV association ( BHIVA ) guidelines for the treatment of HIV - infected adults with antiretroviral therapy ( 2005 ) .", "label": "", "metadata": {}, "score": "59.72152"}
{"text": "Thirty patients older than 18 years , both male and female , which present active tuberculosis and failure or contraindication for any motive to an efavirenz will be selected to participate in the study .", "label": "", "metadata": {}, "score": "60.01982"}
{"text": "Possibility of HIV resistant to ritonavir and possible cross - resistance to other PIs . 1 209 Continued full - dose ritonavir therapy after loss of viral suppression may increase likelihood of cross - resistance to other PIs .", "label": "", "metadata": {}, "score": "60.02812"}
{"text": "However , the fact that the study was carried out with hospitalized patients , who are usually more serious cases , may have led to an increase in the prevalence of hepatotoxicity in the present study .", "label": "", "metadata": {}, "score": "60.0284"}
{"text": "Merck & Co. , Inc. March , 2015 .Kaletra ( lopinavir / ritonavir tablets ) US prescribing information .Abbott Laboratories January , 2013 .", "label": "", "metadata": {}, "score": "60.05423"}
{"text": "[Links ] .Ungo JR , Jones D , Ashkin D , Hollender ES , Bernstein D , Albanese AP , et al .Antituberculosis drug - induced hepatotoxicity .", "label": "", "metadata": {}, "score": "60.149548"}
{"text": "Increased concentrations of indinavir and ritonavir ; 1 26 206 concomitant low - dose ritonavir used to therapeutic advantage ( ritonavir - boosted indinavir ) 200 .", "label": "", "metadata": {}, "score": "60.2147"}
{"text": "Fluticasone nasal spray / oral inhalation : Concomitant use with ritonavir , including low - dose ritonavir , not recommended unless potential benefits outweigh risk of systemic corticosteroid adverse effects 1 200 209 .", "label": "", "metadata": {}, "score": "60.335194"}
{"text": "[ IDIS 484667 ] [ PubMed 12099750 ] .Samaras K , Pett S , Gowers A et al .Iatrogenic Cushing 's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus - infected patients receiving inhaled corticosteroids and ritonavir - boosted protease inhibitors : six cases .", "label": "", "metadata": {}, "score": "60.357113"}
{"text": "[Links ] .Yimer G , Aderaye G , Amogne W , Makonnen E , Aklillu E , Lindquist L , et al .Anti - tuberculosis therapy - induced hepatotoxicity among Ethiopian HIV - positive and negative patients .", "label": "", "metadata": {}, "score": "60.36324"}
{"text": "Unlike PCP , CMV and MAC , TB can be transmitted to otherwise healthy people who live with , care for , or simply come into intimate contact with infected individuals .", "label": "", "metadata": {}, "score": "60.372475"}
{"text": "Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents .If CDAD is suspected or confirmed , ongoing antibacterial use not directed against C. difficile may need to be discontinued .", "label": "", "metadata": {}, "score": "60.446518"}
{"text": "[ PubMed 7486905 ] .Carrillo A , Stewart KD , Sham HL et al .In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378 , a novel protease inhibitor .", "label": "", "metadata": {}, "score": "60.491634"}
{"text": "Unlike PCP , CMV , and other AIDS - related opportunistic infections , TB can be transmitted to otherwise healthy people who live with , care for , or simply come into intimate contact with infected individuals .", "label": "", "metadata": {}, "score": "60.5582"}
{"text": "Low - dose Ritonavir for Ritonavir - boosted PI Regimens .Oral . 4 - 6 mg / kg daily ( 80 - 400 mg daily ) .", "label": "", "metadata": {}, "score": "60.834007"}
{"text": "Colchicine for prophylaxis of gout flares : In those receiving ritonavir , decrease colchicine dosage to 0.3 mg once daily in those originally receiving 0.6 mg twice daily or decrease dosage to 0.3 mg once every other day in those originally receiving 0.6 mg once daily 1 200 209 .", "label": "", "metadata": {}, "score": "60.89759"}
{"text": "The problem is that the tuberculin skin test does n't work very well in people with HIV .Many of them , especially those with more advanced HIV disease , have what is called anergy : their weakened immune systems fail to respond to the skin test even if they have been exposed to TB .", "label": "", "metadata": {}, "score": "61.052074"}
{"text": "[Links ] .Burman WJ , Jones BE .Treatment of HIV - related tuberculosis in the era of effective antiretroviral therapy .Am J Respir Crit Care Med 2001 ; 164:7 - 12 .", "label": "", "metadata": {}, "score": "61.17881"}
{"text": "Geriatric Patients .Select dosage carefully ; initiate therapy at the low end of the dosing range .Cautions for Norvir .Contraindications .Known hypersensitivity ( e.g. , toxic epidermal necrolysis , Stevens - Johnson syndrome ) to ritonavir or any ingredient in the formulation . 1 209 ( See Specific Drugs and Foods under Interactions . )", "label": "", "metadata": {}, "score": "61.18737"}
{"text": "[ IDIS 539333 ] [ PubMed 15755851 ] .Chen F , Kearney T , Robinson S et al .Cushing 's syndrome and severe adrenal suppression in patients treated with ritonavir and inhaled nasal fluticasone .", "label": "", "metadata": {}, "score": "61.354103"}
{"text": "[ IDIS 373811 ] [ PubMed 8813039 ] .Saravolatz LD , Winslow DL , Collins G et al .Zidovudine alone or in combination with didanosine or zalcitabine in HIV - infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter .", "label": "", "metadata": {}, "score": "61.452538"}
{"text": "The current recommendation is that this anti - TB treatment last at least six months .As all those who treat HIV disease now recognize , however , any interruption of combination antiretroviral therapy -- even for periods as brief as a few days -- can result in the development of drug - resistant viral strains .", "label": "", "metadata": {}, "score": "61.4893"}
{"text": "Summary .Diagnosing and treating MDR - TB in HIV - infected patients can be a significant clinical challenge .The key to diagnosis is to maintain a high level of suspicion , especially in persons with epidemiologic risk factors for tuberculosis , and to order appropriate diagnostic studies whenever TB is suspected .", "label": "", "metadata": {}, "score": "61.49569"}
{"text": "Hyperglycemia , new - onset diabetes mellitus , or exacerbation of preexisting diabetes mellitus reported with use of PIs ; diabetic ketoacidosis has occurred .Monitor blood glucose and initiate or adjust dosage of oral hypoglycemic agent or insulin as needed .", "label": "", "metadata": {}, "score": "61.532394"}
{"text": "Long - term use of isoniazid has been associated with liver toxicity -- and , in rare instances , death -- so its administration , especially for the 12-month period that is currently recommended for prophylaxis , is not without risk .", "label": "", "metadata": {}, "score": "61.574326"}
{"text": "Tadalafil for treatment of benign prostatic hyperplasia : Do not exceed tadalafil dosage of 2.5 mg once daily 200 .Manufacturer of ritonavir recommends considering temporarily withholding ritonavir - containing antiretroviral regimens in patients who develop substantial hematologic or GI toxicity : alternatively , consider using a regimen that does not include CYP3A or P - glycoprotein transport system inhibitor 1 209 .", "label": "", "metadata": {}, "score": "61.624"}
{"text": "[Links ] .Kwon YS , Koh WJ , Suh GY , Chung MP , Kim H , Kwon OJ .Hepatitis C virus infection and hepatotoxicity during antituberculosis chemotherapy .", "label": "", "metadata": {}, "score": "61.671032"}
{"text": "Inadequate therapy , due to either poor prescribing practices by physicians or poor compliance by patients , is the most common route by which resistant organisms are acquired .", "label": "", "metadata": {}, "score": "61.709343"}
{"text": "Cardiovascular Effects .Prolongation of PR interval reported .1 209 Second- or third - degree AV block reported during postmarketing monitoring .Dose - dependent prolongation of QT and PR intervals reported with ritonavir - boosted saquinavir ; 193 210 torsades de pointes and second- or third- degree AV block reported rarely .", "label": "", "metadata": {}, "score": "61.926556"}
{"text": "[ PubMed 2143642 ] .Lech WJ , Wang G , Yang YL et al .In vivo sequence diversity of the protease of human immunodeficiency virus type 1 : presence of protease inhibitor - resistant variants in untreated subjects .", "label": "", "metadata": {}, "score": "61.954605"}
{"text": "In case of adverse events during TB therapy that lead to treatment interruption , the study drugs will be delayed until the 30th day after triple therapy for TB .", "label": "", "metadata": {}, "score": "62.044643"}
{"text": "Links ] .Wong WM , Wu PC , Yuen MF , Cheng CC , Yew WW , Wong PC , et al .Antituberculosis drug - related liver dysfunction in chronic hepatitis B infection .", "label": "", "metadata": {}, "score": "62.27031"}
{"text": "Given the extraordinarily high mortality of this disease , and the risk it presents to those who come into close contact with infected individuals , we can not afford to make its treatment less than a top priority .", "label": "", "metadata": {}, "score": "62.45686"}
{"text": "Amitriptyline , imipramine , nortriptyline : Some experts recommend using lowest antidepressant dosage and titrating dosage based on clinical response and/or antidepressant concentrations 200 .Other psychotherapeutics : Use concomitantly with caution ; dosage reduction of the psychotherapeutic agent ( buspirone , nefazodone , perphenazine , risperidone , thioridazine ) may be necessary 1 173 200 209 .", "label": "", "metadata": {}, "score": "62.487003"}
{"text": "1 209 Discontinue ritonavir if a diagnosis of pancreatitis is made .Sensitivity Reactions .Urticaria , mild skin eruptions , bronchospasm , and angioedema have occurred .", "label": "", "metadata": {}, "score": "62.572098"}
{"text": "Adverse experiences were similar to those observed in the adult population , and included leukopenia , neutropenia , and rash .In addition , corneal deposits have been observed in some patients during routine ophthalmologic surveillance of HIV - positive pediatric patients receiving MYCOBUTIN as part of a multiple - drug regimen for MAC prophylaxis .", "label": "", "metadata": {}, "score": "62.837296"}
{"text": "Cases of myopathy , including rhabdomyolysis , have been reported with atorvastatin co - administered with colchicine , and caution should be exercised when prescribing atorvastatin with colchicine .", "label": "", "metadata": {}, "score": "63.009346"}
{"text": "The Lopinavir - Ritonavir dosage will be titrated during the first week of treatment , as follows : . on Days 30 , 31 and 32 : patients will receive lopinavir - ritonavir 400/100 mg ( 2 tablets ) every 12 hours .", "label": "", "metadata": {}, "score": "63.04271"}
{"text": "It is recommended that liver enzyme tests be obtained prior to initiating therapy with Lipitor and repeated as clinically indicated .There have been rare postmarketing reports of fatal and non - fatal hepatic failure in patients taking statins , including atorvastatin .", "label": "", "metadata": {}, "score": "63.220192"}
{"text": "The risk of skeletal muscle effects may be enhanced when Lipitor is used in combination with niacin ; a reduction in Lipitor dosage should be considered in this setting [ see Warnings and Precautions].", "label": "", "metadata": {}, "score": "63.281357"}
{"text": "Melo FAF , Afiune JB , Hiijar MA , Gomes M , Rodrigues DSS , Klatau GB .Tuberculose .In : Veronesi R , Focaccia R , organizadores .", "label": "", "metadata": {}, "score": "63.326"}
{"text": "Pharmacokinetics interactions between Kaletra and other non HIV drugs .5th International Congress on drug therapy in HIV infection .Glasgow UK October 22 - 26 2000 .", "label": "", "metadata": {}, "score": "63.51911"}
{"text": "Oral .100 - 400 mg daily .200 203 204 205 210 211 Specific dosage varies depending on which PI is used ( e.g. , atazanavir , darunavir , fosamprenavir , indinavir , saquinavir , tipranavir ) .", "label": "", "metadata": {}, "score": "63.527584"}
{"text": "Agouron Pharmaceuticals , Inc. March , 2015 .Aptivus ( tipranavir )US prescribing information .Boehringer Ingelheim Pharmaceuticals , Inc. March , 2015 .Fortovase ( saquinavir ) US prescribing information .", "label": "", "metadata": {}, "score": "63.653732"}
{"text": "Links ] .Shakya R , Rao BS , Shrestha B. Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors .Ann Pharmacother 2004 ; 38:1074 - 9 .", "label": "", "metadata": {}, "score": "63.6621"}
{"text": "Jaruratanasirikul S , Sriwiriyajan S. Effect of indinavir on the pharmacokinetics of rifampicin in HIV - infected patients .J Pharm Pharmacol 2001 Mar;53(3):409 - 12 .", "label": "", "metadata": {}, "score": "63.701958"}
{"text": "[ IDIS 394571 ] [ PubMed 9380474 ] .Gallicano K , Foster B , Choudhri S. Effect of short - term administration of garlic supplements on single - dose ritonavir pharmacokinetics in healthy volunteers .", "label": "", "metadata": {}, "score": "63.811874"}
{"text": "When MYCOBUTIN is used concomitantly with clarithromycin for MAC treatment , a decreased dose of MYCOBUTIN is recommended due to the increase in plasma concentrations of MYCOBUTIN ( see PRECAUTIONS : DRUG INTERACTIONS , Table 2 ) .", "label": "", "metadata": {}, "score": "63.877815"}
{"text": "Hepatic toxicity is one of the most common effects that lead to frequent interruptions of treatment 23 .In this study , 36.7 % of the hospitalized coinfected patients who were undergoing tuberculosis treatment presented hepatotoxicity .", "label": "", "metadata": {}, "score": "63.94052"}
{"text": "Inclusion Criteria : .Adults with tuberculosis diagnosis , HIV positive .Agreement to avoid not allowed drugs during the trial , agreement to participate in the study ( informed consent ) .", "label": "", "metadata": {}, "score": "63.962917"}
{"text": "Links ] .Pol S , Lebray P , Vallet - Pichard A. HIV infection and hepatic enzyme abnormalities : intricacies of the pathogenic mechanisms .", "label": "", "metadata": {}, "score": "64.013214"}
{"text": "Higher dose SCC intermittent therapy given in thrice weekly ( 2E3H3R3Z3 , 4H3R3 ) has now been advocated by WHO and implemented by the Revised National TB Control Programme .", "label": "", "metadata": {}, "score": "64.14995"}
{"text": "\u03b2 - Adrenergic blocking agents ( metoprolol , timolol ) .Possible increase in concentrations of the \u03b2 - adrenergic blocking agent 1 209 .Adverse cardiac and neurologic effects reported with \u03b2 - adrenergic blocking agents 1 209 .", "label": "", "metadata": {}, "score": "64.29879"}
{"text": "Am J Gastroenterol 1995 ; 90:1878 - 80 .[Links ] .Erdil A , Kadayifci A , Ates Y , Bagci S , Uygun A , Dagalp K. Rifampicin test in the diagnosis of Gilbert 's syndrome .", "label": "", "metadata": {}, "score": "64.42662"}
{"text": "[Links ] .Pukenyte E , Lescure FX , Rey D , Rabaud C , Hoen B , Chavanet P , et al .Incidence of and risk factors for severe liver toxicity in HIV - infected patients an anti - tuberculosis treatment .", "label": "", "metadata": {}, "score": "64.454895"}
{"text": "HIV infection documented by two positive ELISA tests for HIV and one confirmatory test ( immunoblot or immunofluorescence ) , which may be replaced by a plasma VL using Roche - PCR test , Chiron Branched DNA or NASBA ( BioMerrieux ) .", "label": "", "metadata": {}, "score": "64.460304"}
{"text": "Patients presenting contra indication for the use of those drugs will receive others NRTI .The NNRTI is efavirenz ( 800 or 600 mg ) .", "label": "", "metadata": {}, "score": "64.56212"}
{"text": "[ IDIS 418513 ] [ PubMed 9480994 ] .Chaisson RE , Benson CA , Dube MP et al .Clarithromycin therapy for bacteremic Mycobacterium avium complex disease .", "label": "", "metadata": {}, "score": "64.63869"}
{"text": "Patients are likely to have a nonreactive purified protein derivative ( PPD ) despite active disease .In addition to chest X - ray and sputum culture , the following studies may be useful in the diagnosis of tuberculosis in the HIV - positive patient : blood culture , urine culture , or biopsy of a suspicious lymph node .", "label": "", "metadata": {}, "score": "64.7463"}
{"text": "Of the 156 hospitalized patients that were analyzed , 57 ( 36.7 % ) developed hepatotoxicity .Of this case group , 42 ( 73.7 % ) were diagnosed as presenting hepatotoxicity on the basis of laboratory criteria and 15 ( 26.3 % ) solely on the basis of clinical criteria .", "label": "", "metadata": {}, "score": "64.78563"}
{"text": "This patient will be excluded of the study , but he will be able to be treated and accompanied in the responsible sites for the study up to the end of the tuberculosis treatment if it is the wish of the patient .", "label": "", "metadata": {}, "score": "64.8019"}
{"text": "Prevalence of TB and Human Immunodeficiency Virus ( HIV ) co - infection worldwide is 0.18 % and about 8 % TB cases have HIV infection .", "label": "", "metadata": {}, "score": "64.88003"}
{"text": "For example , a lack of information in the medical files compromised some analyses important tothe study , such as the HIV viral load , body weight , ethnicity , smoking habits and use of illegal drugs .", "label": "", "metadata": {}, "score": "65.04074"}
{"text": "References : .Invirase ( saquinavir mesylate ) US prescribing information .Roche Laboratories , Inc. April , 2015 .Agenerase ( amprenavir ) Capsules US prescribing information .", "label": "", "metadata": {}, "score": "65.06781"}
{"text": "AIDS .1997 ; 11:F95 - 9 .[ PubMed 9342060 ] .Centers for Disease Control and Prevention .Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus : principles of therapy and revised recommendations .", "label": "", "metadata": {}, "score": "65.13684"}
{"text": "[Links ] .World Health Organization .Antiretroviral therapy for HIV infection in adults and adolescents : recommendations for a public health approach .Geneva : World Health Organization ; 2006 .", "label": "", "metadata": {}, "score": "65.19657"}
{"text": "J Am Med Inform Assoc 2012 Sep - Oct ; 19(5):735 - 43 .Treatment by Condition Related to elvitegravir - cobicistat - emtricitabin - tenofovir disoprox .", "label": "", "metadata": {}, "score": "65.22511"}
{"text": "Hepatic impairment : Decreased ritonavir concentrations in patients with moderate hepatic impairment compared with individuals with normal hepatic function .Infants 1 - 24 months of age : Ritonavir trough concentrations in infants receiving 350 - 450 mg / m 2 of ritonavir twice daily were lower than concentrations reported in adults receiving 600 mg of ritonavir twice daily . 1 183 209 Higher ritonavir exposures not observed with 450 mg / m 2 twice daily compared with 350 mg / m 2 twice daily in these infants .", "label": "", "metadata": {}, "score": "65.30365"}
{"text": "Corticosteroids ( dexamethasone , fluticasone , prednisone ) .Fluticasone nasal spray / oral inhalation : Increased fluticasone concentrations resulting in decreased cortisol concentrations ; systemic corticosteroid effects ( Cushing 's syndrome , adrenal suppression ) reported with concomitant ritonavir 1 175 176 177 178 179 180 181 182 200 209 .", "label": "", "metadata": {}, "score": "65.333374"}
{"text": "[Links ] .Huang YS , Chern HD , Su WJ , Wu JC , Lai SL , Yang SY , et al .Polymorphism of the N - acetyltransferase-2 gene as a susceptibility risk factor for antituberculosis drug - induced hepatitis .", "label": "", "metadata": {}, "score": "65.35816"}
{"text": "Hormonal contraceptives : Decreased peak plasma concentrations of ethinyl estradiol with oral or transdermal contraceptive preparations 1 79 209 .Atorvastatin , lovastatin , rosuvastatin , pitavastatin , pravastatin , simvastatin : Decreased clearance and increased concentrations of the statin with potential for increased risk of statin - associated adverse effects , including myopathy and rhabdomyolysis 1 186 209 .", "label": "", "metadata": {}, "score": "65.43932"}
{"text": "On initiation of therapy , perform frequent bacteriologic evaluations to document sputum conversion to culture - negative status -- and , after culture conversion , to detect possible treatment failure .", "label": "", "metadata": {}, "score": "65.69924"}
{"text": "Another strategy used was the temporary discontinuation of treatment with the reintroduction of the drugs one after the other .Although this approach is recommended by certain authors 22 , there is no consensus on the most effective way of reintroducing these drugs .", "label": "", "metadata": {}, "score": "65.87065"}
{"text": "Doses of MYCOBUTIN may be administered mixed with foods such as applesauce .Geriatric Use .Clinical studies of MYCOBUTIN did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects .", "label": "", "metadata": {}, "score": "65.88786"}
{"text": "Culture of mycobacteria is a much more sensitive test than smear examination and has been estimated to detect 10 - 100 viable mycobacteria per ml of sample and in case of active disease they are found to be 81 % sensitive and 98.5 % specific .", "label": "", "metadata": {}, "score": "66.09862"}
{"text": "Witvrouw M , Pannecouque C , Switzer WM et al .Susceptibility of HIV-2 , SIV and SHIV to various anti - HIV-1 compounds : implications for treatment and postexposure prophylaxis .", "label": "", "metadata": {}, "score": "66.29123"}
{"text": "These were included because they showedsignificance in the bivariate analyses at levels of less than or equal to 0.20 .The variables smoking and use of illegal drugs were not included because they presented percentage losses of information greater than 30 % .", "label": "", "metadata": {}, "score": "66.30963"}
{"text": "Use only indinavir with OPTION # 3 .Use directly - observe - therapy ( DOT ) throughout the course of anti - TB treatment .", "label": "", "metadata": {}, "score": "66.653465"}
{"text": "Zidovudine .No effect on ritonavir pharmacokinetics ; decreased zidovudine peak concentrations and AUC 1 209 .Norvir Pharmacokinetics .Absorption .Bioavailability .Well absorbed from GI tract ; peak plasma concentrations attained within 2 - 4 hours ( fasting ) .", "label": "", "metadata": {}, "score": "66.87454"}
{"text": "Links ] .Anand A , Seth AK , Paul M. Risk factors of hepatotoxicity during antituberculosis treatment .Medical Journal Armed Forces India 2006 ; 62:45 - 9 .", "label": "", "metadata": {}, "score": "67.0072"}
{"text": "Manufacturers of indinavir and ritonavir state that appropriate dosages with respect to safety and efficacy not established 1 206 209 .When ritonavir - boosted indinavir is used , some experts suggest indinavir 800 mg twice daily with ritonavir 100 or 200 mg twice daily 200 .", "label": "", "metadata": {}, "score": "67.05327"}
{"text": "However , most of these studies were ofoutpatients and it should be emphasized that the percentages observed by the present study relate to hospitalized patients and that this fact may have contributed towards a higher incidence rate in the present study .", "label": "", "metadata": {}, "score": "67.0827"}
{"text": "Another important issue involves the duration of treatment of MDR - TB .Treatment of MDR - TB requires at least nine months of therapy , and often as much as 24 months .", "label": "", "metadata": {}, "score": "67.162796"}
{"text": "Vancouver , BC , 1996 Jul 7 - 12 .Abstract No .Mo . B.171 .Delta Coordinating Committee .Delta : a randomised double - blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV - infected individuals .", "label": "", "metadata": {}, "score": "67.367035"}
{"text": "[ IDIS 362747 ] [ PubMed 8568296 ] .Centers for Disease Control and Prevention .US Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women .", "label": "", "metadata": {}, "score": "67.451324"}
{"text": "From Day 36 until day 180 : patients will receive lopinavir - ritonavir 800/200 mg ( 4 tablets ) every 12 hours , unless reduced on day 60 ( refer to section 14.6 ) .", "label": "", "metadata": {}, "score": "67.5289"}
{"text": "Hepatic Effects .Hepatic dysfunction ( including some fatalities ) reported ; causal relationship not established .1 209 Generally has occurred in patients with advanced HIV infection and/or receiving multiple concomitant drugs .", "label": "", "metadata": {}, "score": "67.55696"}
{"text": "The frequency of hepatoxicity caused by tuberculostatics varies in accordance with the type of definition used for this event , as observed by Coca et al .", "label": "", "metadata": {}, "score": "67.62312"}
{"text": "Adults .Treatment of HIV Infection .Full - dose Ritonavir .Oral .Initially 300 mg twice daily ; increase dosage every 2 - 3 days by 100 mg twice daily up to a dosage of 600 mg twice daily .", "label": "", "metadata": {}, "score": "67.67242"}
{"text": "Reproduction studies have been carried out in rats and rabbits given rifabutin using dose levels up to 200 mg / kg ( about 6 to 13 times the recommended human daily dose based on body surface area comparisons ) .", "label": "", "metadata": {}, "score": "67.67692"}
{"text": "Nevertheless , these limitations were of minimal significance because this was a uniform population receiving care at two university hospitals that have medical residence programs in infectology so ensuring better quality annotations in the medical files .", "label": "", "metadata": {}, "score": "67.68388"}
{"text": "1998 ; 47(No .RR-20):1 - 58 .Melvin AJ , Mohan KM , Manns Arcuino LA et al .Clinical , virologic and immunologic responses of children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors .", "label": "", "metadata": {}, "score": "67.77367"}
{"text": "If treatment of uterine atony and excessive postpartum bleeding is indicated in a woman receiving ritonavir , use methylergonovine maleate ( Methergine ) only if alternative treatments can not be used and if potential benefits outweigh risks ; use methylergonovine at lowest dosage and shortest duration possible 202 .", "label": "", "metadata": {}, "score": "68.440735"}
{"text": "Hepatotoxicidade foi definida como icter\u00edcia ou alta concentra\u00e7\u00e3o de ALT / AST ou de bilirrubinemia total .Coinfec\u00e7\u00e3o pelos v\u00edrus das hepatites B e C e linf\u00f3citos T CD4 + abaixo de 200 c\u00e9lulas / mm 3 foram fatores de risco independentes para a hepatotoxicidade nesses pacientes .", "label": "", "metadata": {}, "score": "68.76808"}
{"text": "Clin Infect Dis 2010 ; 50:833 - 9 .[Links ] .Omerod LP , Skimer C , Wales J. Hepatotoxicity of antituberculosis drugs .", "label": "", "metadata": {}, "score": "68.98126"}
{"text": "If an alternate etiology is not found , do not restart Lipitor .Endocrine Function .Increases in HbA1c and fasting serum glucose levels have been reported with HMG - CoA reductase inhibitors , including Lipitor .", "label": "", "metadata": {}, "score": "69.01471"}
{"text": "Nearly 20 % of patients in an HV treatment programme in Kenya have suffered major interactions between their HIV drugs and other prescribed medicines , a study has found .", "label": "", "metadata": {}, "score": "69.07587"}
{"text": "[Links ] .Pan L , Jia Z , Chen L , Fu E , Li G. Effect of anti - tuberculosis therapy on liver function of pulmonary tuberculosis patients infected with hepatitis B virus .", "label": "", "metadata": {}, "score": "69.12958"}
{"text": "N Engl J Med .[ IDIS 373810 ] [ PubMed 8813038 ] .Katzenstein DA , Hammer SM , Hughes MD et al .The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV - infected adults with 200 to 500 CD4 cells per cubic millimeter .", "label": "", "metadata": {}, "score": "69.15961"}
{"text": "However , certain studies disagree with this association , possibly because they were conducted with a small number of patients with the hepatitis B or C viruses 37,38,39,40 .", "label": "", "metadata": {}, "score": "69.17406"}
{"text": "Other risk factors include exposure to a patient with MDR - TB , being from a country with a high prevalence of MDR - TB ( such as Mexico or the Philippines ) , and living in a community with greater than 4 % resistance to isoniazid .", "label": "", "metadata": {}, "score": "69.36593"}
{"text": "DIAGNOSIS OF TB : .Since TB is an infectious disease caused by Mycobacterium ( M ) tuberculosis the diagnosis of TB should ( as far as possible ) be by demonstration of M. tuberculosis on culture or acid - fast bacilli ( AFB ) on smear examination .", "label": "", "metadata": {}, "score": "69.53392"}
{"text": "Geriatric Use .Select dosage with caution because of age - related decreases in hepatic , renal , and/or cardiac function and concomitant disease and drug therapy .", "label": "", "metadata": {}, "score": "70.02504"}
{"text": "Because it is known that the risk of myopathy during treatment with HMG - CoA reductase inhibitors is increased with concurrent administration of other fibrates , Lipitor should be administered with caution when used concomitantly with gemfibrozil or other fibrates [ see Warnings and Precautions].", "label": "", "metadata": {}, "score": "70.238075"}
{"text": "Pancreatitis ( sometimes fatal ) with or without marked elevations in triglycerides has occurred .Patients with advanced HIV disease may be at increased risk of elevated triglycerides and pancreatitis .", "label": "", "metadata": {}, "score": "70.29989"}
{"text": "Reyataz ( atazanavir sulfate ) US prescribing information .Bristol - Myers Squibb Company March , 2015 .Reyataz ( atazanavir sulfate )Australian product information .", "label": "", "metadata": {}, "score": "70.528114"}
{"text": "The usual short course chemotherapy is indicated in HIV positive patients .The response is usually good but relapse is frequent .After initiating ATT or anti - retroviral therapy ( ART ) worsening of preexisting lesions or appearance of new lesions is seen , \" paradoxical response \" or \" immune reconstitution phenomenon \" .", "label": "", "metadata": {}, "score": "70.76193"}
{"text": "[Links ] .Harries A , Maher D , Graham S. TB / HIV : a clinical manual .2 nd Ed .Geneva : World Health Organization ; 2004 .", "label": "", "metadata": {}, "score": "70.78567"}
{"text": "1995 ; 44(No .RR-7):1- 15 .Spooner KM , Lane HC , Masur H. Guide to major clinical trials of antiretroviral therapy administered to patients infected with human immunodeficiency virus .", "label": "", "metadata": {}, "score": "70.81099"}
{"text": "There was no follow - up of the clinical consequences of the interactions in the study , so it 's impossible to say if any were implicated in subsequent deaths , though there do not appear to have been deaths due to acute interactions .", "label": "", "metadata": {}, "score": "70.84453"}
{"text": "Tablets are not bioequivalent to capsules .209Tablets may result in higher peak plasma ritonavir concentrations ; patients may experience more adverse GI effects ( e.g. , nausea , vomiting , abdominal pain , diarrhea ) when switching from capsules to tablets .", "label": "", "metadata": {}, "score": "70.86435"}
{"text": "Pitavastatin : Dosage adjustments not necessary if pitavastatin used concomitantly with ritonavir - boosted PI regimens 200 .Pravastatin : If used concomitantly with certain ritonavir - boosted PI regimens ( e.g. , ritonavir - boosted darunavir ) , titrate statin dosage using lowest possible starting dosage and closely monitor for adverse effects 200 .", "label": "", "metadata": {}, "score": "71.076904"}
{"text": "In the past , a simple skin test , administered in your care provider 's office , was sufficient to determine if you had been exposed to TB .", "label": "", "metadata": {}, "score": "71.214035"}
{"text": "2000 ; 161:S221 - 47 .Lewis - Hall FD .Dear healthcare professional letter : Change in labeling for Deseryl ( trazodone hydrochloride ) tablets .", "label": "", "metadata": {}, "score": "71.351746"}
{"text": "Pregnancy : All drugs , that is , rifampicin , isoniazid , ethambutol , and pyrazinamide can be used during pregnancy .Streptomycin is not given due to ototoxicity to the fetus .", "label": "", "metadata": {}, "score": "71.93233"}
{"text": "A study of 346 patients undergoing tuberculosis treatment showed that age was an independent risk factor for the development of hepatotoxicity 28 .However , other studies have demonstrated an absence of correlation between age and the occurrence of hepatotoxicity 29,30,31 .", "label": "", "metadata": {}, "score": "71.94142"}
{"text": "Pre - existing liver disease : In stable disease with normal liver enzymes , all anti - tuberculous drugs may be used but frequent monitoring of liver function tests is required .", "label": "", "metadata": {}, "score": "72.01592"}
{"text": "Prezista ( darunavir ) US prescribing information .Tibotec Inc.May , 2015 .Lexiva ( fosamprenavir calcium ) US prescribing information .GlaxoSmithKline March , 2015 .", "label": "", "metadata": {}, "score": "72.13825"}
{"text": "The association of each variable with the presence of hepatotoxicity was evaluated by means of the Mann - Whitney test at a significance level of 0.20 for rejection of the null hypothesis of absence of association between the variables .", "label": "", "metadata": {}, "score": "72.14178"}
{"text": "Male and female subjects , with HIV infection and an active tuberculosis diagnosis .Women must have a negative pregnancy test and use a birth control method ( barrier or Depo - Provera contraceptive ) throughout the study and at investigator 's discretion considered as reliable .", "label": "", "metadata": {}, "score": "72.157684"}
{"text": "[Links ] .Posey D , Mozayani A. The estimation of blood alcohol concentration .Forensic Science , Medicine , and Pathology 2007 ; 3:33 - 9 .", "label": "", "metadata": {}, "score": "72.21561"}
{"text": "Pediatric Dosage of Full - dose Ritonavir Using Oral Solution209 . 4.7 mL ( 375 mg ) .5.5 mL ( 437.5 mg ) .6.25 mL ( 500 mg ) . 4.7 mL ( 375 mg ) .", "label": "", "metadata": {}, "score": "72.476685"}
{"text": "API TB Consensus Guidelines 2006 : Management of pulmonary tuberculosis , extra - pulmonary tuberculosis and tuberculosis in special situations .Abstract .INTRODUCTION : .", "label": "", "metadata": {}, "score": "72.73085"}
{"text": "Updates may be available at HHS AIDS Information ( AIDSinfo ) website .Panel on Antiretroviral Therapy and Medical Management of HIV - infected Children , US Department of Health and Human Services ( HHS ) .", "label": "", "metadata": {}, "score": "72.94266"}
{"text": "Conduzimos estudo caso - controle para identificar fatores de risco para hepatotoxicidade entre pacientes com tuberculose e infec\u00e7\u00e3o pelo HIV em dois hospitais de Recife , Pernambuco , Brasil .", "label": "", "metadata": {}, "score": "72.944115"}
{"text": "BJID , 1(3 ) : 123 - 130 , 1997 ; .WHO ( WORLD HEALTH ORGANIZATION ) .Scaling up antiretroviral therapy in resource - limited settings .", "label": "", "metadata": {}, "score": "73.33915"}
{"text": "Use with caution in patients with preexisting liver disease , liver enzyme abnormalities , or hepatitis ; consider more frequent monitoring of AST and ALT , especially during the first 3 months .", "label": "", "metadata": {}, "score": "73.56069"}
{"text": "Sildenafil ( Revatio ) for treatment of PAH : Concomitant use with ritonavir ( including low - dose ritonavir ) contraindicated ; 1 200 209 ritonavir manufacturer states that a safe and effective dose for concomitant use not established 1 209 .", "label": "", "metadata": {}, "score": "74.24457"}
{"text": "The information loss relating to this variable corresponded to 39.1 % of the patients in this study , thereby demonstrating that the medical files were inadequately kept .", "label": "", "metadata": {}, "score": "74.278824"}
{"text": "Drug interactions were divided into major interactions ( meaning ones that were life - threatening or required hospital admission or treatment for the interaction ) , moderate ( causing deterioration in clinical status and/or dose modification of at least one drug ) and minor ( bothersome but not requiring intervention ) .", "label": "", "metadata": {}, "score": "74.386665"}
{"text": "Pregnancy or breast feeding .Gender .Both .Ages .18 Years and older .Accepts Healthy Volunteers .No .Contacts ICMJE .Contact information is only displayed when the study is recruiting subjects Mycobutin . \"", "label": "", "metadata": {}, "score": "74.39362"}
{"text": "In rats , given 200 mg / kg / day , ( about 6 times the recommended human daily dose based on body surface area comparisons ) , there was a decrease in fetal viability .", "label": "", "metadata": {}, "score": "74.44667"}
{"text": "From FDA website .Accessed 2012 Apr 23 .Panel on Antiretroviral Guidelines for Adults and Adolescents , US Department of Health and Human Services ( HHS ) .", "label": "", "metadata": {}, "score": "74.555916"}
{"text": "These indicators put Brazil in 19 th place in the world ranking of absolute numbers of tuberculosis cases and in 104 th place in terms of incidence rate 5 .", "label": "", "metadata": {}, "score": "74.564095"}
{"text": "Part 1 : first - line drugs .J Bras Pneumol 2010 ; 36:626 - 40 .[Links ] .Arbex MA , Varella MC , Siqueira HR , Mello FA .", "label": "", "metadata": {}, "score": "74.59225"}
{"text": "Contact your healthcare professionals ( e.g. doctor or pharmacist ) as soon as possible about taking these two medicines together .They may already be aware of this interaction and may be monitoring you for it .", "label": "", "metadata": {}, "score": "75.13686"}
{"text": "In HIV - infected patients with MDR - TB , the most common presenting symptoms are fever , night sweats , cough , and shortness of breath ( Table ) .", "label": "", "metadata": {}, "score": "75.157486"}
{"text": "Recently it has been shown that sputum smear positivity is greater than 90 % where greater than 5 ml of sputum is used for smear diagnosis of pulmonary TB .", "label": "", "metadata": {}, "score": "75.23715"}
{"text": "Severe .These medicines may interact and cause very harmful effects and are usually not taken together .Contact your healthcare professional ( e.g. doctor or pharmacist ) for more information .", "label": "", "metadata": {}, "score": "75.419945"}
{"text": "A 10-year experience in a Medical Center .Medicine ( Baltimore ) 2007 ; 86:39 - 46 .[Links ] .Arbex MA , Varella MC , Siqueira HR , Mello FA .", "label": "", "metadata": {}, "score": "75.44095"}
{"text": "Substantial increases in total serum cholesterol and triglyceride concentrations have occurred .Determine serum triglyceride and cholesterol concentrations prior to and periodically during therapy ; manage lipid disorders as clinically appropriate . 1 209 ( See Specific Drugs and Food under Interactions . )", "label": "", "metadata": {}, "score": "75.53842"}
{"text": "The most frequent manifestation of hepatotoxicity was toxic hepatitis with jaundice ( 31 cases or 56.4 % of the total ) of which 23 cases(63.9 % ) appeared more than 15 days after the start of the treatment of tuberculosis .", "label": "", "metadata": {}, "score": "75.56593"}
{"text": "Advice to Patients .Critical nature of compliance with HIV therapy and importance of remaining under the care of a clinician . 1 209 Importance of taking as prescribed ; do not alter or discontinue antiretroviral regimen without consulting clinician .", "label": "", "metadata": {}, "score": "76.29227"}
{"text": "Patient agrees not to use any medication ( even herbal medications or natural products ) without previous knowledgement and consent from investigator throughout the study .", "label": "", "metadata": {}, "score": "76.32716"}
{"text": "Pregnancy .Only limited experience using full - dose ritonavir in pregnant women ; low concentrations reported .202 Some experts state that ritonavir should only be given as low - dose ritonavir in conjunction with another PI ( ritonavir - boosted PI regimens ) in pregnant women .", "label": "", "metadata": {}, "score": "76.414215"}
{"text": "[ IDIS 369501 ] [ PubMed 8816123 ] .Bertz R , Shi H , Cavanaugh J et al .Effect of three vehicles , Advera , Ensure and chocolate milk , on the bioavailability of an oral liquid formulation of Norvir .", "label": "", "metadata": {}, "score": "76.838356"}
{"text": "Study Type ICMJE .Interventional .Study Phase .Phase 4 .Study Design ICMJE .Allocation : Randomized Endpoint Classification : Safety / Efficacy Study Intervention Model : Parallel Assignment Masking : Open Label Primary Purpose : Treatment .", "label": "", "metadata": {}, "score": "77.02771"}
{"text": "Postmarketing Experience .There have been rare postmarketing reports of cognitive impairment ( e.g. , memory loss , forgetfulness , amnesia , memory impairment , confusion ) associated with statin use .", "label": "", "metadata": {}, "score": "77.13921"}
{"text": "[Links ] .Sirinak C , Kittikraisak W , Pinjeesekikul D , Charusuntonsri P , Luanloed P , Srisuwanvilai LO , et al .Viral hepatitis and HIV - associated tuberculosis : risk factors and TB treatment outcomes in Thailand .", "label": "", "metadata": {}, "score": "77.17947"}
{"text": "Oral midazolam or triazolam : Possible increased benzodiazepine concentrations ; potential for prolonged or increased sedation or respiratory depression 1 209 .Clorazepate , diazepam , estazolam , flurazepam : Possible increased concentrations of the benzodiazepine 1 209 .", "label": "", "metadata": {}, "score": "77.25351"}
{"text": "If this skin test produced a firm welt , not much bigger than a pimple , that meant that you had been exposed to tuberculosis .", "label": "", "metadata": {}, "score": "77.26962"}
{"text": "Spontaneous bleeding noted with PIs ; causal relationship not established .Caution in patients with a history of hemophilia type A or B. 1 48 119 209 Increased hemostatic ( e.g. , antihemophilic factor ) therapy may be needed .", "label": "", "metadata": {}, "score": "77.387856"}
{"text": "[Links ] .Vieira DEO , Gomes M. Adverse effects of tuberculosis treatment : experience at an outpatient clinic of a teaching hospital in the city of S\u00e3o Paulo , Brazil .", "label": "", "metadata": {}, "score": "77.495605"}
{"text": "J Gastroenterol Hepatol 2005 ; 20:1745 - 52 .[Links ] .Wang JY , Hsueh PR , Wang SK , Jan IS , Lee LN , Liaw YS , et al .", "label": "", "metadata": {}, "score": "77.58422"}
{"text": "Asymptomatic elevations of hepatic transferases may occur in more than 20 % of patients during the first two months of treatment , with a return to normal values as the therapy proceeds 9 .", "label": "", "metadata": {}, "score": "77.798584"}
{"text": "Hepatotoxicity due to antituberculosis drugs limits treatment in patients coinfected with HIV and tuberculosis .We conducted a case - control study to identify risk factors for hepatotoxicity among patients coinfected with tuberculosis and HIV in two hospitals in Recife , Pernambuco State , Brazil .", "label": "", "metadata": {}, "score": "77.89779"}
{"text": "Compared with administration in the fasting state , extent of absorption was decreased 7 % when ritonavir oral solution was administered with a meal .Dilution of ritonavir oral solution with 240 mL of chocolate milk , Advera , or Ensure not associated with clinically important changes in rate or extent of absorption .", "label": "", "metadata": {}, "score": "78.30553"}
{"text": "Patients and methods .A retrospective case - control study was conducted in the wards of two referral hospitals for infectious diseases in the city of Recife , Pernambuco State .", "label": "", "metadata": {}, "score": "78.49904"}
{"text": "The research project was approved by the Ethics Committees for Research Involving Human Beings of the Health Sciences Center of UFPE ( protocol n\u00ba. CEP / CCS / UFPE 370/07 ) and of the Oswaldo Cruz University Hospital of UFPE ( protocol n\u00ba. CEP / HUOC 146/2007 ) .", "label": "", "metadata": {}, "score": "78.64696"}
{"text": "This monograph has been modified to include the generic and brand name in many instances .TB or Not TB .Do You Have Tuberculosis ?", "label": "", "metadata": {}, "score": "78.821686"}
{"text": "This may have been because of the failure to record such information in the medical files or because little importance was given to this factor by individuals .", "label": "", "metadata": {}, "score": "79.3087"}
{"text": "Renal failure : Dosages may have to be adjusted according to the creatinine clearance especially for streptomycin , ethambutol and isoniazid .In acute renal failure , ethambutol should be given 8 hours before hemodialysis .", "label": "", "metadata": {}, "score": "79.44595"}
{"text": "Links ] .Shakya R , Rao BS , Shrestha B. Evaluation of risk factors for antituberculosis drug - induced hepatotoxicity in Nepalese population .Kathmandu University Journal of Science , Engineering and Technology 2006 ; II:1 - 8 .", "label": "", "metadata": {}, "score": "79.49791"}
{"text": "J Infect 1999 ; 38:162 - 6 . [Links ] .Corbett EL , Watt CJ , Walker N , Maher D , Williams BG , Raviglione MC , et al .", "label": "", "metadata": {}, "score": "79.582054"}
{"text": "The HIV - infected patients were aged between 17 and 65 years and were hospitalized at the above study locations between January 2004 and October 2007 .", "label": "", "metadata": {}, "score": "79.86707"}
{"text": "This might be explained in part by the occurrence of greater numbers of opportunistic infections and therefore by the consumption of a greater number of drugs 37,41,42,43 .", "label": "", "metadata": {}, "score": "79.92885"}
{"text": "Updates may be available at HHS AIDS Information ( AIDSinfo ) website .Panel on Treatment of HIV - Infected Pregnant Women and Prevention of Perinatal Transmission , US Department of Health and Human Services ( HHS ) .", "label": "", "metadata": {}, "score": "80.20831"}
{"text": "Oral midazolam or triazolam : Concomitant use contraindicated 1 200 209 .Clorazepate , diazepam , estazolam , flurazepam : Use with caution ; reduced benzodiazepine dosage may be needed 1 209 .", "label": "", "metadata": {}, "score": "80.70261"}
{"text": "The information is not intended to cover all possible uses , directions , precautions , drug interactions or adverse effects , nor should it be construed to indicate that use of a particular drug is safe , appropriate or effective for you or anyone else .", "label": "", "metadata": {}, "score": "80.88924"}
{"text": "Links ] .Hoffmann C , Rockstroh JK , Kamps BS .HIV Medicine 2006 .Paris : Flying Publisher ; 2007 .[Links ] .", "label": "", "metadata": {}, "score": "80.9301"}
{"text": "BRASIL , MINIST\u00c9RIO DA SA\u00daDE , 2006 .Recomenda\u00e7\u00f5es para o tratamento de adultos e adolescentes infectados pelo virus HIV .5th International Congress on Drug Therapy in HIV Infection , Glasgow , UK ( October 22 - 26 , 2000 ) .", "label": "", "metadata": {}, "score": "81.14767"}
{"text": "This finding was also reported by a study conducted in India 28 .Furthermore , no association between self - reported skin color and hepatotoxicity was identified by the present study .", "label": "", "metadata": {}, "score": "81.25416"}
{"text": "The information provided through The Body should not be used for diagnosing or treating a health problem or a disease .It is not a substitute for professional care .", "label": "", "metadata": {}, "score": "81.98282"}
{"text": "Actual costs to patients will vary depending on the use of specific retail or mail - order locations and health insurance copays .Norvir 80MG / ML Solution ( ABBOTT ) : 240/$1,508.58 or 720/$4,525.74 .", "label": "", "metadata": {}, "score": "82.0186"}
{"text": "Very often these levels spontaneously return to normal with the continuation of treatment 20,21 .With regard to behavioral factors , alcohol consumption , smoking and use of illegal drugs , such as marijuana , crack , cocaine and solvents , was less frequent in group A than in group B : however , these differences were not significant .", "label": "", "metadata": {}, "score": "82.07675"}
{"text": "Autoimmune disorders ( e.g. , Graves ' disease , polymyositis , Guillain - Barr\u00e9 syndrome ) have been reported to occur in the setting of immune reconstitution ; the time to onset is more variable and can occur many months after initiation of antiretroviral therapy .", "label": "", "metadata": {}, "score": "82.25002"}
{"text": "Data sources include Micromedex \u00ae ( updated Jan 25th , 2016 ) , Cerner Multum \u2122 ( updated Feb 1st , 2016 ) , Wolters Kluwer \u2122 ( updated Feb 1st , 2016 ) and others .", "label": "", "metadata": {}, "score": "82.645645"}
{"text": "The model was initially saturated by including all the variables .Stepwise removal of each variable from the proposed model was tested and its significance was expressed as a p - value using the maximum likelihood test .", "label": "", "metadata": {}, "score": "82.77929"}
{"text": "Brazil is one of 22 countries prioritized by the WHO that together account for 80 % of the world 's TB cases .In 2007 Brazil notified 72,194 new cases , representing an incidence rate of 38/100,000 inhabitants .", "label": "", "metadata": {}, "score": "83.123535"}
{"text": "Distributed into milk in rats ; 202 not known whether distributed into human milk .Instruct HIV - infected women not to breast - feed because of risk of HIV transmission and risk of adverse effects in the infant .", "label": "", "metadata": {}, "score": "83.30459"}
{"text": "Updates may be available at HHS AIDS Information ( AIDSinfo ) website .About .Terms & Privacy .Connect .Subscribe to receive email notifications whenever new articles are published .", "label": "", "metadata": {}, "score": "83.47203"}
{"text": "45 and Shakya et al .46 .In more than 60 % of the cases , the tuberculosis treatment was successfully maintained or temporarily interrupted and then gradually restarted ( drug by drug ) after the hepatotoxicity had been resolved .", "label": "", "metadata": {}, "score": "83.63229"}
{"text": "For example , the CAGE or AUDIT questionnaires can be used , or Widmark 's method , which considers blood alcohol level calculated from the patient 's alcohol intake 49 .", "label": "", "metadata": {}, "score": "83.82817"}
{"text": "Changing regimen I ( IRZ ) is not a routine recommendation , since itis the most potentand shortest term regimen used in Brazil .Reintroduction drug - by - drug ( new challenge ) is a practice that has also been recommended by Kwon et al .", "label": "", "metadata": {}, "score": "83.98532"}
{"text": "Links ] .Correspondence : M. F. S. Lima Hospital das Cl\u00ednicas de Pernambuco Av .Submitted on 08/Dec/2009 Final version resubmitted on 07/Jan/2012 Approved on 16/Jan/2012 One in five Kenyan patients suffers major interactions between HIV drugs and other medicines .", "label": "", "metadata": {}, "score": "84.16163"}
{"text": "Possible increased concentrations of the calcium - channel blocking agent 1 209 .Monitor patient ; caution advised ; reduced dosage of the calcium - channel blocking agent may be necessary 1 209 .", "label": "", "metadata": {}, "score": "84.195724"}
{"text": "47 , and many patients will tolerate this regimen without any change in the medication .In the present study , the frequency of change in regimen of 17 % is similar to that cited for individuals without HIV infection 48 .", "label": "", "metadata": {}, "score": "84.282455"}
{"text": "S\u00e3o Paulo : Universidade de S\u00e3o Paulo ; 2006 .[Links ] .Minist\u00e9rio da Sa\u00fade .Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no Brasil .", "label": "", "metadata": {}, "score": "84.352745"}
{"text": "Norvir Dosage and Administration .Administration .Oral Administration .Capsules .Solution .Administer using calibrated dosing syringe when possible .209Agitate solution prior to each dose .", "label": "", "metadata": {}, "score": "84.722916"}
{"text": "[Links ] .Tosi CH , Ngangro MN , Djimadoum N , Richard V. Study of HIV seroprevalence in patients with pulmonary tuberculosis in 1999 in Chad .", "label": "", "metadata": {}, "score": "84.97105"}
{"text": "Robert M. Jasmer , M.D. , is a Senior Fellow at the Division of Pulmonary and Critical Care Medicine , University of California , San Francisco .", "label": "", "metadata": {}, "score": "85.21417"}
{"text": "Food .Administration with food delays time to peak plasma concentrations by 2 hours .Compared with administration in the fasting state , extent of absorption was increased 13 % when ritonavir capsules were administered with a meal ( 615 kcal , 14.5 % fat , 9 % protein , 76 % carbohydrate ) .", "label": "", "metadata": {}, "score": "85.43666"}
{"text": "Lancet .[ IDIS 400430 ] [ PubMed 9492772 ] .Carr A , Samaras K , Chisholm DJ et al .Pathogenesis of HIV-1-protease inhibitor- associated peripheral lipodystrophy , hyperlipidaemia , and insulin resistance .", "label": "", "metadata": {}, "score": "85.7456"}
{"text": "Pak J Med Sci 2007 ; 23:33 - 8 .[Links ] .Koju D , Rao BS , Shrestha B , Shakya R , Makaju R. Occurrence of side effects from antituberculosis drugs in urban Nepalese population under dots treatment .", "label": "", "metadata": {}, "score": "86.07845"}
{"text": "Am J Respir Crit Care Med 1998 ; 157:1871 - 6 . [Links ] .Coca NS , Oliveira MS , Voieta I , Antunes CM , Lambertucci JR .", "label": "", "metadata": {}, "score": "86.20023"}
{"text": "Only just over 4 % of interactions counted as minor ones , probably because such reactions did not usually get recorded .Two hundred and thirteen patients had one interaction recorded , 51 had two , 11 had three and one unfortunate patient had four .", "label": "", "metadata": {}, "score": "86.26351"}
{"text": "Constitutional symptoms , such as weight loss , anorexia , and chills , are also frequently reported .If you have one or more of these symptoms -- especially in combination with one or more epidemiologic risk factors for TB exposure -- you should consult your doctor immediately . \"", "label": "", "metadata": {}, "score": "86.34123"}
{"text": "Advise patients that ECG changes ( PR prolongation ) have occurred ; importance of consulting clinician if dizziness , lightheadedness , abnormal heart beats , or loss of consciousness occurs .", "label": "", "metadata": {}, "score": "86.90934"}
{"text": "1 209 ( See Specific Drugs and Foods under Interactions . )Introduction .Uses for Norvir .Treatment of HIV Infection .Treatment of HIV-1 infection in conjunction with other antiretrovirals .", "label": "", "metadata": {}, "score": "87.12559"}
{"text": "Arch Intern Med 2003 ; 163:1009 - 21 .[Links ] .Hospital das Cl\u00ednicas , Faculdade de Medicina , Universidade de S\u00e3o Paulo .", "label": "", "metadata": {}, "score": "87.62204"}
{"text": "Curr .Drug Metab . , 5(4):321 - 8 , 2004 .10th EACS , Dublin 2005 .Poster PE7.9/3 .PEDRAL - SAMPAIO DB , NETTO EM , ALC\u00c2NTARA AP , SOUZA J , MOURA L , BRITES C ET AL .", "label": "", "metadata": {}, "score": "87.715515"}
{"text": "The latter form related to conditions involving bloodstream , bone marrow , liver or two or more non - contiguous sites 19 .The outcomes ofthe cases were classified as discharge or death .", "label": "", "metadata": {}, "score": "87.873886"}
{"text": "The reports are generally nonserious , and reversible upon statin discontinuation , with variable times to symptom onset ( 1 day to years ) and symptom resolution ( median of 3 weeks ) .", "label": "", "metadata": {}, "score": "87.91568"}
{"text": "Half - life .Stability .Storage .Oral .Capsules .2 - 8 \u00b0 C until dispensed .1 Protect from light . 1 Avoid exposure to excessive heat .", "label": "", "metadata": {}, "score": "88.05605"}
{"text": "Possible redistribution or accumulation of body fat , including central obesity , dorsocervical fat enlargement ( \" buffalo hump \" ) , peripheral wasting , breast enlargement , and general cushingoid appearance .", "label": "", "metadata": {}, "score": "88.09831"}
{"text": "Eur J Clin Pharmacol 2001 May;57(2):115 - 21 .Phansalkar S , Desai AA , Bell D , Yoshida E , Doole J , Czochanski M , Middleton B , Bates DW .", "label": "", "metadata": {}, "score": "88.217636"}
{"text": "Links ] .Ozick LA , Jacob L , Comer GM , Lee TP , Ben - Zvi J , Donelson SS , et al .", "label": "", "metadata": {}, "score": "88.55627"}
{"text": "PATIENT INFORMATION .What are the Possible Side Effects of Lipitor ?Liver problems --- Your doctor should do blood tests to check your liver before you start taking Lipitor , and if you have symptoms of liver problems while you take Lipitor .", "label": "", "metadata": {}, "score": "88.74799"}
{"text": "3 a Ed .S\u00e3o Paulo : Editora Atheneu ; 2005 .p. 1139 - 206 .[Links ] .Marshall BG , Mitchell DM , Shaw RJ , Marais F , Watkins RM , Coker RJ .", "label": "", "metadata": {}, "score": "88.780106"}
{"text": "Cyclosporine : .The co - administration of Lipitor with cyclosporine should be avoided].Gemfibrozil : .Due to an increased risk of myopathy / rhabdomyolysis when HMG - CoA reductase inhibitors are co - administered with gemfibrozil , concomitant administration of Lipitor with gemfibrozil should be avoided .", "label": "", "metadata": {}, "score": "88.82385"}
{"text": "20 - 25 \u00b0 C ( may be exposed to 15 - 30 \u00b0 C ) .Oral Solution .20 - 25 \u00b0 C ; store and dispense in original container .", "label": "", "metadata": {}, "score": "89.143036"}
{"text": "Part 2 : second line drugs .J Bras Pneumol 2010 ; 36:641 - 56 .[Links ] .Sharma KS , Singla R , Sarda P , Mohan A , Makharia G , Jayaswal A , et al .", "label": "", "metadata": {}, "score": "89.32222"}
{"text": "This period of ticd as follows : .Data was organized using the Epi Info software , version 6.04d ( Centers for Disease Control and Prevention , Atlanta , USA ) and analyzed using the Statistical Package for Social Sciences ( SPSS Inc. , Chicago , USA ) software , version 13.0 .", "label": "", "metadata": {}, "score": "89.47136"}
{"text": "1 209 ( See Specific Drugs and Foods under Interactions . )Warnings / Precautions .Interactions .Concomitant use with certain drugs is contraindicated because of risk of life - threatening adverse events , significant interaction , or loss of virologic activity . 1 209 200 Concomitant use with other drugs may require caution , dosage adjustments , and/or increased monitoring . 1 200 209 ( See Specific Drugs and Foods under Interactions . )", "label": "", "metadata": {}, "score": "89.720215"}
{"text": "Country of origin is another risk factor : patients born in countries with a high prevalence of tuberculosis run an increased risk of infection because of exposure to TB in their homeland prior to immigration .", "label": "", "metadata": {}, "score": "89.749695"}
{"text": "Find a Drug or Condition .Drug Condition Enter a drug name .Use the arrow keys to navigate suggestions .Norvir .Warning(s ) .", "label": "", "metadata": {}, "score": "89.815094"}
{"text": "In more than 80 % of the cases , it started within the first 29 days of treatment .The predominant form of hepatotoxicity was jaundice ( in 56.4 % of the cases ) .", "label": "", "metadata": {}, "score": "89.96802"}
{"text": "Reference .Kigen G et al ( presenter Khoo S ) .Prevalence of drug interactions between antiretroviral and co - administered drugs in Kenya .", "label": "", "metadata": {}, "score": "90.24045"}
{"text": "Bras\u00edlia : Minist\u00e9rio da Sa\u00fade ; 2010 .[Links ] .Diniz LS , Gerhardt G , Miranda JA , Manceau JN .Efetividade do tratamento da tuberculose em 22 munic\u00edpios de capitais brasileiras e Distrito Federal .", "label": "", "metadata": {}, "score": "90.426575"}
{"text": "Importance of informing clinician of existing or contemplated concomitant therapy , including prescription and OTC drugs and dietary or herbal supplements ( e.g. , St. John 's wort ) , and any concomitant illnesses . 1 209 Should not be used in patients receiving avanafil for treatment of erectile dysfunction 188 or sildenafil for treatment of PAH .", "label": "", "metadata": {}, "score": "90.58475"}
{"text": "If a dosage of 400 mg / m 2 twice daily is not tolerated ( due to adverse effects ) , use highest dosage that is tolerated or consider use of an alternative PI .", "label": "", "metadata": {}, "score": "91.1526"}
{"text": "When tablets are used , importance of taking with a meal .209When capsules or oral solution are used , take with a meal if possible .", "label": "", "metadata": {}, "score": "91.46552"}
{"text": "Rev Soc Bras Med Trop 2010 ; 43:624 - 8 .[Links ] .Agal S , Baijal R , Pramanik S , Patel N , Gupte P , Kamani P , et al .", "label": "", "metadata": {}, "score": "92.1501"}
{"text": "Liver Enzymes .It is recommended that liver enzyme tests be performed before the initiation of Lipitor and if signs or symptoms of liver injury occur .", "label": "", "metadata": {}, "score": "93.0842"}
{"text": "NAM 's information is intended to support , rather than replace , consultation with a healthcare professional .Talk to your doctor or another member of your healthcare team for advice tailored to your situation .", "label": "", "metadata": {}, "score": "94.39124"}
{"text": "Patients should date and sign volunteer the informed consent before entering in the study and after a full explanation of the study nature .If the patient is unable , his / her legally authorized representative will sign on his / her behalf .", "label": "", "metadata": {}, "score": "94.82521"}
{"text": "[ PubMed 9715843 ] .Johne A , Brockmoller J , Bauer S et al .Pharmacokinetic interaction of digoxin with an herbal extract from St. John 's wort ( Hypericum perforatum ) .", "label": "", "metadata": {}, "score": "95.134796"}
{"text": "[Links ] .Fern\u00e1ndez - Villar A , Sope\u00f1a B , V\u00e1zquez R , Ulloa F , Fluiters E , Mosteiro M , et al .", "label": "", "metadata": {}, "score": "95.74191"}
{"text": "Contributors .M. F. S. Lima made a substantial contribution to the conception and design of this study and data collection , analysis and interpretation . H. R. L. Melo contributed to drafting and reviewing the article for its technical content .", "label": "", "metadata": {}, "score": "96.60713"}
{"text": "The Body and its logos are trademarks of Remedy Health Media , LLC , and its subsidiaries , which owns the copyright of The Body 's homepage , topic pages , page designs and HTML code .", "label": "", "metadata": {}, "score": "96.918335"}
{"text": "1 209 Advise HIV - infected women not to breast - feed .Importance of advising patients of other important precautionary information . 1 209 ( See Cautions . )", "label": "", "metadata": {}, "score": "97.226944"}
{"text": "Talk with your doctor and family members or friends about deciding to join a study .To learn more about this study , you or your doctor may contact the study research staff using the Contacts provided below .", "label": "", "metadata": {}, "score": "97.546036"}
{"text": "By Robert M. Jasmer , M.D. and Laurence Huang , M.D. From San Francisco General Hospital .October 1997 .As a result , parts of this article may be outdated .", "label": "", "metadata": {}, "score": "97.946976"}
{"text": "Increased tadalafil concentrations and increased risk of tadalafil - associated adverse effects ( e.g. , hypotension , visual disturbances , prolonged erection ) 1 200 209 .", "label": "", "metadata": {}, "score": "98.89853"}
{"text": "This finding may have been due to the fact that more than 85 % of the cases were individuals up to 50 years of age .", "label": "", "metadata": {}, "score": "99.85356"}
{"text": "In : XI International Conference on AIDS , 1996 : Abstracts - on - disk .Vancouver , BC , 1996 Jul 7 - 12 .", "label": "", "metadata": {}, "score": "101.68319"}
{"text": "This copyrighted material has been downloaded from a licensed data provider and is not for distribution , expect as may be authorized by the applicable terms of use .", "label": "", "metadata": {}, "score": "102.04744"}
{"text": "Presenter Dr Saye Khoo of the University of Liverpool commented that the number of interactions found was a minimum .Firstly , many patients might have suffered interactions but not reported them to healthcare workers .", "label": "", "metadata": {}, "score": "103.7991"}
{"text": "Traditional medicines were also not recorded .The AMPATH Project currently treats 55,000 people with HIV in and around the town of Eldoret in north - western Kenya , with 2,000 new patients registering every month .", "label": "", "metadata": {}, "score": "105.22879"}
{"text": "Vancouver , BC , 1996 Jul 7 - 12 .Abstract No .Mo .B.1197 .Hammer SM , Katzenstein DA , Hughes MD et al .", "label": "", "metadata": {}, "score": "106.56045"}
{"text": "Vancouver , BC , 1996 Jul 7 - 12 .Abstract No .Mo .B.1200 .Bertz RJ , Cao G , Cavanaugh JH et al .", "label": "", "metadata": {}, "score": "108.41667"}
{"text": "Abstract O121 .HATIP # 122 , 14th November 2008 .This content was checked for accuracy at the time it was written .It may have been superseded by more recent developments .", "label": "", "metadata": {}, "score": "112.36899"}
{"text": "Links ] .Instituto Brasileiro de Geografia e Estat\u00edstica .Brasil : 500 anos de povoamento .Rio de Janeiro : Instituto Brasileiro de Geografia e Estat\u00edstica ; 2000 .", "label": "", "metadata": {}, "score": "114.34337"}
{"text": "Polk RE , Brophy DF , Israel DS , Patron R , Sadler BM , Chittick GE , Symonds WT , Lou Y , Kristoff D , Stein DS .", "label": "", "metadata": {}, "score": "115.89668"}
{"text": "Not Provided .Recruitment Information .Recruitment Status ICMJE .Terminated .Enrollment ICMJE .Completion Date .October 2012 .Primary Completion Date .October 2012 ( final data collection date for primary outcome measure ) .", "label": "", "metadata": {}, "score": "116.179115"}
{"text": "\u00a9 Copyright , 2004 - 2016 , Selected Revisions September 25 , 2012 .American Society of Health - System Pharmacists , Inc. , 7272 Wisconsin Avenue , Bethesda , Maryland 20814 .", "label": "", "metadata": {}, "score": "118.49054"}
{"text": "As a result , parts of this article may be outdated .Please keep this in mind , and be sure to visit other parts of our site for more recent information !", "label": "", "metadata": {}, "score": "123.57341"}
